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Abstract 
Sudden cardiac death (SCD) is a prominent cause of death worldwide today, mainly 
occurring as a result of coronary heart disease, cardiomyopathies, and inherited or induced 
arrhythmia syndromes. Survival following sudden cardiac arrest (SCA) has improved in the 
past decades, but the majority of cases of SCD remain unwitnessed. Although advances have 
been made towards the investigation of the mechanisms behind SCD, it remains a poorly 
understood phenomenon. Environmental factors have been identified and associated with 
increased arrhythmic risk, and most prominently, drug-induced arrhythmias constitute a 
serious hurdle to both cardiac and non-cardiac drug development. The past decade has seen 
pro-arrhythmic screening of new compounds become routine, and develop into a major point 
of interest for drug development. Specifically, the onset of drug-induced polymorphic 
ventricular tachycardia, such as torsade de pointes (TdP), is of particular interest to cardiac 
research. The concept of electrophysiological heterogeneity in cardiac muscle holds exciting 
potential for explaining the pathophysiology of TdP, but quantifying cellular heterogeneity 
using conventional methods is a challenge. 
This work developed and refined a fluorescence-based, medium/high-throughput 
electrophysiological assay to process large cell populations (~50-500 cells) from single 
hearts. Using this novel approach, transmural electrophysiological differences were found 
between regions of individual hearts, replicating published work with a 3 to 4-fold reduction 
in hearts sampled, and additionally providing a previously unknown quantification of 
cellular heterogeneity in isolated cardiomyocyte populations, in both healthy and failing 
rabbit hearts. 
Further classification of electrophysiological differences within smaller regions of the 
ventricle yielded evidence of repolarisation gradients across the myocardium, with vast 
overlap in repolarisation duration, challenging the dogma of region-specific repolarisation 
duration. Lastly, by specifically blocking hERG channels and L-type calcium channels in 
cardiac subregions (sub-epicardial apex and base) strong evidence was found for 
heterogeneous electrophysiology response amongst isolated cell populations. Specifically, 
sub-epicardial action potential shortening using nifedipine was strongly APD dependent, 
whereby baseline AP duration determined the extent of APD shortening via drug-induced 
ICa-L blockade. Sub-epicardial AP prolongation mediated via IKr block using dofetilide also 
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produced non-homogeneous cell response in the form of two distinct population responses: 
(i) The majority (~85%) was made up of normal responding cells, experiencing ~20-30ms 
AP prolongation not dependent on baseline APD  (P<0.001), and (ii) hyper-responding cells 
(~15% of total) experiencing >100ms AP prolongation, beyond the pacing cycle length 
(>500ms) without any evidence of early-afterdepolarisations. 
Large experimental samples of AP parameters gathered in this study can provide real-world 
data parameter space ranges for mathematical model development, showing that ion channel 
conductance ranges used today to predict drug responses at the organ level may be too 
restrictive, or inaccurate. Iterative model adjustment using large experimental datasets can 
help constrain models and improve their predictive power, saving time by reducing 
computational power required. 
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1.1 Cardiovascular disease and sudden cardiac death 
(SCD) 
Cardiovascular disease (CVD) is the most common cause of death in industrialised countries 
(Chappex et al., 2015). As the incidence of obesity, diabetes, and coronary heart disease 
continues to rise, an increase in the rate of sudden cardiac death (SCD), from complications 
of coronary disease and heart failure is almost inevitable (Okrainec et al. 2004; Chugh et al. 
2008). A limited understanding of fatal arrhythmogenesis has driven research into the 
mechanisms of SCD caused by congenital heart diseases (Myerburg, 2002), and despite 
extensive insights gained in the past 30 years, remains extremely challenging to predict or 
prevent (Myerburg and Junttila, 2012). Additionally, congenital heart disease has also been 
increasing in prevalence in the past few decades (Khairy, 2016), shifting from a previously 
paediatric to a predominantly adult demographic (2:1) in the past 10 years, due to increased 
survival (Marelli et al., 2014). Adults with congenital heart disease are highly prone to 
arrhythmic anomalies, due to genetic anomalies, as well as scarring, tissue hypoxia and other 
malformations in the heart conduction system (Khairy et al., 2014). Lastly, SCD prevalence 
in athletes, whereby otherwise healthy individuals suffer a sudden and unexplained cardiac 
arrest demands further research into the mechanisms underlying lethal ventricular 
arrhythmias. 
1.2 Cardiac function 
1.2.1 Excitation-Contraction coupling 
The propagation of electrical activation throughout the myocardium is carried by the action 
potential. Its shape and duration vary across excitable tissues of the heart, most notably 
between atrium and ventricles (Figure 1.1). To result in a coordinated muscular contraction 
expelling blood efficiently, the electrical activation must be coordinated throughout the heart 
muscle in a spatially and temporally precise way. Activation initiates in the sinoatrial node 
(SAN) from specialized pacemaker cells and propagates through the atrial tissue. The atrium 
and ventricles are electrically isolated from one another, ensuring atrial contraction always 
precedes ventricular contraction. The signal reaches the atrioventricular node (AVN), which 
in turn relays the impulse through the His-Purkinje system in the heart septum. The inward-
facing surface (endocardium) of the ventricles is activated, propagating the signal 
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transmurally via gap junctions outward to the outer surface (epicardium), resulting in co-
ordinated ventricular contraction (systole). 
The summated electrical activity of the heart can be observed externally by placing 
electrodes on the chest and limbs (i.e. 12-lead electrocardiogram) (Figure 1.1). On the ECG 
trace, the P-wave is caused by the depolarising atria, closely followed by the QRS complex, 
representing ventricular depolarisation. The T-wave shows the repolarising phase of the 
ventricles, allowing for K+ to exit the cells and calcium to unbind, resulting in muscle 
relaxation (diastole). The QT-interval duration is used as a marker of normal ventricular 
function. As discussed later, a change, generally positive, in the QT interval duration is a 
valuable indicator of altered electrical ventricular function, which can result from a change 
in regulatory proteins and/or ion channel transport and expression, in both acquired and 
inherited disease (Bartos, Grandi and Ripplinger, 2015). 
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Figure 1.1 Diagrammatic representation of a cardiac electrocardiogram (ECG) 
demonstrating the respective influence of atrial and ventricular action potentials to the P-
wave, and QRS complex + T-wave, respectively. 
 
 
Figure 1.2 Excitation-contraction coupling Example fluorescent signals showing membrane 
potential (black), Ca2+ (green) and sarcomere length overlaid on the same timescale, 
demonstrating the synergistic relationship between cellular excitation (AP upstroke), Ca2+ 
release, and muscle contraction (cell shortening) contributing to excitation-contraction 
coupling. (Signals were recorded from a single isolated rabbit ventricular cardiomyocyte) 
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1.2.2 The ventricular action potential 
The action potential is composed of 5 major phases (0-4) shown in Figure 1.3, each phase is 
the result of a delicate balance of ionic currents caused by ion channels, dynamically 
controlling the membrane potential (Em) of the cell. 
The duration of an action potential hinges on the balance between inward and outward ionic 
currents. The voltage-gated Na+ channel mediates phase 0 through rapid activation and de-
activation. Phase 1 mediates rapid repolarisation by two components of the transient outward 
K+ channels (Ito,f; fast, and Ito,s; slow). Phase 2 and 3 are the product of competition between 
inward currents voltage-gated L-type channels and the Na+/Ca2+ exchanger (NCX), and 
outward K+ currents mediated by the voltage-gated delayed rectifier K+ channels, IK 
(Carmeliet, 1999). 
 
Figure 1.3 Ventricular action potential AP diagram and associated inward (Na+, Ca2+) and 
outward (K+) currents activation and deactivation patterns over the time-course of the 
action potential. (Diagram taken from Jost, 2009). 
The hERG potassium channel was the primary channel of interest in this work, responsible 
for the dominant component of action potential duration, mediated by the rapid component 
of the delayed rectifier K+ current (IKr). 
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1.2.3 Regional electrical differences 
The heart is composed of structurally and physiologically distinct regions of myocardium. 
These are divided in several categories, which can be roughly divided along planes. These 
respectively separate: atria from ventricles, right- from left-ventricle, apex from base, or 
transmurally, endocardium from epicardium. Amongst these divisions, the nodal cell (SAN 
and AVN) electrophysiology differs most markedly from the rest, in that they depolarise 
spontaneously and drive the intrinsic rhythm of the heart without requiring external 
activation. Atrial and ventricular action potentials also differ from one another both in AP 
morphology and duration (see Figure 1.4 and Figure 1.6). The ion channels responsible for 
these differences are predominantly the voltage-gated Na+ channels, (Nav), and K
+ channels 
(Kv), resulting in a faster upstroke (phase 0) and a longer plateau phase (phase 2) in ventricle 
cells compared with atrial cells. Different AP morphologies have been identified within the 
ventricle itself. For example, cells originating from the epicardium of the LV have been 
shown to have longer action potentials than endocardial LV cells, which may be due to 
different expressions of K+ channels (Schram et al., 2002). This endocardium/epicardium 
difference has already been demonstrated (McIntosh et al., 1998). 
 
Figure 1.4 Cardiac action potential subtypes Diagrammatic representation of the types of 
AP duration and morphologies across the major cardiac tissues (Taken from Bartos, 
Grandi and Ripplinger, 2015). 
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Figure 1.5 Cardiac regions studied in this work Diagram of the left-ventricular regional sub-
division which were electrophysiologically compared in this work. 
 
Figure 1.6 Action potentials from SA node, atrium and ventricle of rabbit Example action 
potential shapes of nodal cell, atrial and ventricular cardiomyocytes generated using the 
APSim program written by Dr John Dempster. Respective cell models from: (Dokos, 
Celler and Lovell, 1996; Inada et al., 2009; Davies et al., 2012). 
The varying expression and function of ion channels in different regions of the heart strongly 
drives AP duration and morphology (see Figure 1.7). In the intact heart, action potential 
heterogeneity is greatly reduced at a local scale by cellular coupling via connexins. In 
isolated cells, cell-specific channel expression becomes the main driver of AP duration, 
displaying heterogeneity far exceeding that of coupled tissue. This inherent variation is 
thought to contribute to the stabilisation of the action potential duration, and in turn of the 
repolarisation reserve. Down- or mis-regulation of these stabilising currents has been shown 
to increase the incidence of arrhythmic events (Pogwizd et al., 2001). 
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Figure 1.7 Transmural and apicobasal action potentials Example single cell traces of 
recorded fluorescent action potentials originating from different regions of the heart 
(acquired in this thesis, and normalised to upstroke maximum). (a) Shows epicardium 
(black) versus endocardium (red) differences in repolarisation duration. (b) Shows a 
comparable difference in APD between epicardium base (black) and apex (red).  
1.2.4 Calcium and contraction 
As the cardiac action potential propagates, it causes rapid depolarisation of the plasma 
membrane (sarcolemma) of individual cardiomyocytes, which is rapidly carried deep into 
the cell via transverse tubule (T-tubules) networks (See Figure 1.8). This causes calcium to 
diffuse into the cell, down its concentration gradient, predominantly through L-Type calcium 
channels (LTCC). This gradient is due to a high extracellular concentration of Ca2+ ions 
outside the cell (~2 mM) at rest (diastole), contrasted with 80-250 nM inside the cell 
cytoplasm. This calcium influx causes calcium-induced calcium release (CICR) via 
ryanodine receptors (RyRs) from the sarcoplasmic reticulum (SR), where calcium is stored 
at rest. This rapid calcium release transiently increases the intracellular calcium 
concentration 2 to 4-fold, to ~0.5-2 µM. Calcium ions bind to troponin-C, exposing the actin 
filaments to myosin. Contraction occurs, and the sarco/endoplasmic reticulum Ca2+-ATPase 
(SERCA) pumps Ca2+ back into the sarcoplasmic reticulum (SR), lowering Ca
2+ 
concentration in the cytoplasm, and terminating contraction. Membrane potential, 
intracellular calcium concentration and fractional shortening were measured from single 
cardiomyocytes in this work using fluorescent methods (see Figure 1.2). 
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Figure 1.8 Schematic representation of Ca2+ entry and role in ventricular myocyte 
contraction. Inset diagram showing temporal relationship between excitation (action 
potential, black line), intracellular Ca2+ (calcium transient, blue line) and contraction (red 
dashed line). (ATP, ATPase; NCX, Na+/Ca2+ exchanger; PLB, phospholamban; SR, 
sarcoplasmic reticulum; RyR, Ryanodine receptor). (Figure taken from Bers (2002) Nature 
415, 198-205). 
1.2.5 The force-frequency relationship 
In the healthy myocardium, an increase in stimulation frequency is followed by a change in 
contractile force. This effect is often referred to as the staircase, Bowditch, or Treppe effect. 
This relationship is either positive of negative, depending on the species. Positive staircases 
are seen in human, rabbit and others (Gibbons and Fozzard, 1975; Wang et al., 1988; Maier, 
Bers and Pieske, 2000), and negative in rat, mouse, most fish and other species (Orchard, 
1985; Maier, Bers and Pieske, 2000; Shiels, Vornanen and Farrell, 2002). 
An increase in stimulation frequency causes increases Ca2+ influx per unit time, due to higher 
frequency of APs, and subsequent L-type Ca2+ channel activation. This increases 
intracellular Ca2+ load, and in particular, SR Ca2+ content. The resulting increased Ca2+ 
transient amplitude in turn increases NCX-mediated Ca2+ efflux, such that the cell reaches a 
new steady state of Ca2+ flux balance, whereby NCX efflux increases to match L-type Ca2+ 
channel-mediated Ca2+ influx. 
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1.3 Cardiac arrhythmias 
Arrhythmias can be defined as disruptions in the rate and/or order of activation and recovery 
of electrical activation in the heart (Tse, 2016). These occur on a range, from transient, 
benign events, to fatal conditions. Some arrhythmias can be as simple as bradycardia (i.e. 
slower than 60 beats.min-1), common and mostly harmless in athletes, to tachycardia (i.e. 
faster than 100 beats.min-1). The athlete heart can have an intrinsic rhythm as low as 30 bpm 
(Jensen-Urstad, Saltin and Jensen-Urstad, 1997), less than half the typical rate encountered 
in untrained individuals, in itself a prime example of the broad range of what can be 
considered “normal” electrophysiologically. More complex forms of arrhythmic events 
manifest themselves throughout the myocardium. Broadly speaking, the presence of an 
abnormal event in the electrophysiology of the heart is either the result of the de novo 
generation of an electrical wave which is not normally present, or the failure to terminate an 
event which does occur in normal physiology. Ectopic activity describes the former, and 
afterdepolarisations the latter. Ectopic focus can originate from inappropriate balance in 
sympathetic/parasympathetic drive, as well as ion channel expression changes in previously 
non-pacemaker tissue. Early afterdepolarisations (EADs), formerly defined as “oscillations 
at the plateau level of membrane potential or later during phase 3 of repolarisation” (Volders 
et al., 2000), and generally occur as a result of L-type calcium channels reactivating at a 
membrane potential sufficient for re-activation of voltage-gated calcium channels, before 
the end of the AP (Maruyama et al., 2011). They range from small positive deflections of 
the plateau phase, prolonging the APD, to full APs overlapping the one preceding them. 
Delayed afterdepolarisations (DADs) are part of phase 4 and may themselves cause ectopic 
beats. They are caused by an inward sodium/calcium exchanger (NCX) current induced by 
spontaneous SR Ca2+ release (see Figure 1.9). This is thought to be caused by excess 
intracellular calcium, which drives the NCX to pump in 3 sodium ions for 1 calcium ion out. 
This net positive charge builds up and depolarises the cell enough to cause an upstroke. 
Interestingly, DADs have been reported in the midmyocardium but not either in the 
epicardial or endocardial layers (Antzelevitch et al., 1991). 
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Figure 1.9. Examples of early-afterdepolarisation subtypes a. Diagrammatic representation 
of ventricular action potential. b. Phase 2 early-afterdepolarisation. c. Phase 3 early-
afterdepolarisation. d. Delayed afterdepolarisation. 
1.3.1 Long-QT syndrome 
The electrocardiogram (ECG) trace reflects summation of action potential depolarisation and 
repolarisations of cardiomyocytes in the heart (Tse et al., 2017), measured using 3-12 
electrodes on the chest and limbs. The P-wave constitutes the depolarisation of the atria, 
followed by the QRS complex, which marks the depolarisation of the ventricles, followed 
by the T-wave, where the ventricles repolarise. Measurements made using these waves 
provides valuable information about the electrical state of the heart. The QT interval is a 
measure of the time between upstroke (Q-wave) and end of repolarisation (P-wave) (Jaiswal 
and Goldbarg, 2014). Because the repolarisation time is rate-dependent, QT will vary as a 
function of heart rate, and therefore requires correction before comparing absolute QT 
durations. A correction index for QT expressed as QTc is therefore calculated. Several 
methods exist to calculate QTc, most prominently by dividing QT by a factor related to the 
R-R interval (Bazett or Friedericia formulae). Generally, however, QT = QTc is assumed at 
heart rates of 60 beats/min as the aforementioned methods of calculating QTc tend to lose 
predictive power in strongly brady- and tachy-cardiac states (Jaiswal and Goldbarg, 2014). 
The necessity for standardisation of QT-interval durations becomes clear when defining 
upper limits for risk assessment. These limits are defined at 450 ms in males and 470 ms in 
females (Cubeddu, 2009), although the latest guidelines from the European Society of 
Cardiology suggest limits of 360 – 480 ms for both females and males (Priori et al. 2015). 
This gender discrepancy in the form of a reduced repolarisation reserve has been proposed 
to correlate with oestrogen, supported by higher rates of cardiac events in pre-pubertal boys 
and adult women (Drici and Clément, 2001). 
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Figure 1.10 Diagrammatic examples of normal and abnormal long-QT ECG traces. LQT1 is 
represented by a slower and longer T-wave. LQT3 is caused by a delayed normal 
duration T-wave.  
Congenital long-QT syndrome (cLQTS) is characterized by a prolongation of the QT 
interval in the ECG trace. It is a relatively rare disorder inherited at a rate of 1:5000 to 1:2000 
of the general population, and can be caused by either a decrease in repolarising currents or 
an increase in depolarising currents (Tse et al., 2017). While over a dozen subtypes have 
been identified, LQT1-3 make up 75% of cases observed (see Figure 1.10), respectively 
caused by mutations in KCNQ1, KCNH2 and SCN5A genes. LQT1 and LQT2 are both loss 
of function mutations affecting repolarising potassium currents (IKr and IKs, respectively), 
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while LQT3 causes a gain of function by increasing INa current function and thus promoting 
action potential duration (APD) prolongation. 
The prolongation of APD, in these examples, is caused by three different mechanisms, which 
underlines the crucial notion of interplay and redundancy present in cardiac 
electrophysiology, where different initial states can result in undistinguishable AP 
morphologies. The simplified net result of these three mutations is a prolongation of the 
action potential, which decreases the repolarisation reserve (Roden, 2006), in turn increasing 
the risk of arrhythmia. 
1.3.1.1 Acquired LQTS 
While genetic mutations described previously are relatively uncommon, acquired LQTS is 
by far the more prominent form encountered in the clinic, manifesting itself as a result of a 
variety of factors, but predominantly drug administration (diLQTS)(Kannankeril and Roden, 
2007). The female sex, hypokalaemia, atrioventricular block, and bradycardia are amongst 
the rest of the risk factors for acquired LQTS (Drici and Clément, 2001; Kallergis et al., 
2012). Work carried out in by Dessertene and colleagues (Motté et al, 1970) demonstrated 
symptom reversal was achievable through increased chronotropy and normalising of serum 
potassium. As described by Roden (2006), the key feature of the acquired form of ventricular 
arrhythmias resulting from QT prolongation is its unpredictability. 
The establishment of drug-induced QT prolongation affirmed itself during the 1970s, as an 
increasing number of cases of torsade de pointes (TdP) were being reported, notably 
following quinidine administration, the only drug used for managing atrial fibrillation (AF) 
at the time (Schwartz et al., 2016; Selzer & Wray 1964; Friedberg 1966). Investigations of 
the effects of electrolyte imbalance (hypokalaemia) on the arrhythmogenic mechanisms of 
LQTS, using a hypokalaemia mouse model, found APD prolongation also increased EAD 
propensity and ensuing triggered activity (Killeen et al., 2007). This occurs by increasing 
time spent at voltages within L-type Ca2+ channel activation ranges increasing [Ca2+]i. EADs 
can initiate arrhythmias, and can lead to the development of a specific polymorphic 
ventricular arrhythmia, torsade de pointes (see Figure 1.11). First described in 1966 by 
Dessertenne (Dessertenne, 1966), TdP is characterised as a “twisting of spikes” ECG trace, 
and has a high propensity to degenerate into ventricular fibrillation (VF), a major cause of 
sudden cardiac death. 
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Figure 1.11 Example trace of Torsades. ECG trace in a patient experiencing an episode of 
Torsade de Pointes. The distinct pattern of this form PVT is visibly twisting around the 
isoelectric line. 
Although no mention of LQT was originally made by François Dessertenne and colleagues 
(Selzer and Wray, 1964) with regards to TdP, it is now known numerous compounds causing 
LQT also increase risk for TdP, as discussed later (Fenichel et al., 2004). 
1.4 Potassium channels in arrhythmia 
The KCNH2 gene, known as the human Ether-a-go-go-Related gene (hERG), codes for the 
Kv11.1 protein making up the channel responsible for the rapidly activating delayed inward 
rectifier (IKr) current. IKr is a key player in the repolarisation phase of the action potential, 
and consequently mediates its duration. Pharmacological blockade of hERG leads to 
increased AP duration, and consequently increased QT-interval duration on the ECG trace. 
Many TdP-inducing drugs (Dofetilide, E4031) tend to block IKr. Mechanisms underlying 
drug-induced TdP closely resemble the congenital form of long-QT (Schwartz, Woosley and 
Woosley, 2016). IKr blockade prolongs the action potential plateau (phase 2) and mimics the 
genetic loss of function in LQT1/2 seen in congenital long QT syndrome. 
Anti-arrhythmic drugs, perhaps ironically, make up the bulk of QT-prolonging compounds; 
they are however far from unique in this aspect, as several other drug types, including 
antibiotics (erythromycin), antipsychotics (Thioridazine) and anti-histamines also populate 
the ever-expanding list of LQT-inducing compound (Niemeijer et al., 2015; Yang et al., 
2014; McComb et al., 1984; Kornick et al., 2003). 
Much of the inhibitory compounds targeting hERG target its α-subunit. While hERG-
blockade is a definite risk factor toward QT prolongation and TdP, not all drugs blocking it 
produce QT prolongation, nor does it always cause TdP. The basis for this apparent 
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discrepancy is unknown, and presents a substantial hurdle to drug development, causing 
withdrawal of clinically important drugs from the market (Day, McComb and Campbell, 
1990; Monahan et al., 1990; Schwartz, Woosley and Woosley, 2016). 
With regards to the propensity to SCD following LQTS, several groups (Soyka, Wirtz and 
Spangenberg, 1990; Hohnloser, van de Loo and Baedeker, 1995; Torp-Pedersen et al., 1999) 
found long-term exposure to QT-prolonging anti-arrhythmic drugs increased incidence of 
TdP by 1-3%. Amiodarone is an illustrative example of a drug which increases the QT-
interval without increasing propensity of SCD, although there is still controversy regarding 
its benefit over placebo (Al-khatib et al. 2017; Bardy et al. 2005) This highlights the fact that 
the link between the two may not be a straightforward causal relationship. 
The mechanism behind this apparent inconsistency in drug effects, including compounds 
causing LQT but not TdP, or TdP without LQT may stem from additional interactions, 
perhaps acting on several ion channels and proteins together, thus amplifying or cancelling 
out effects depending on local expression levels of involved proteins. 
1.4.1 Torsade de Pointes (TdP) 
Torsade de Pointes was first described by Dessertenne in 1966 as a twisting of the QRS 
complex around the isoelectric line. It is now classified as a form of polymorphic ventricular 
tachycardia. Although it can terminate spontaneously, it does not necessarily do so 
predictably, as the initiating electrical event can be identical to the terminating one (Kriklerl 
et al., 1976). It can recur, and potentially degenerate into ventricular fibrillation. 
The mechanisms underlying the pathophysiology of TdP are still unexplained. Despite being 
extensively studied, and known to severely undermine drug development, TdP prediction 
and prevention is still a major problem today. Its incidence in patient populations is also 
difficult to measure, because it requires an ECG to be taken during such an episode, which 
is often transient, and is known to spontaneously terminate. Furthermore, it is estimated that 
roughly 1 in 20 cases of TdP could currently be misinterpreted and reported as VT, VF or 
unexplained death, as the patient may die prior to an ECG being taken (Molokhia et al., 
2008). 
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1.5 Pharmacological screening for pro-arrhythmic 
potential 
The importance of successfully identifying new drugs likely to cause long-QT, and, 
potentially, increase risk of TdP cannot be understated. Regulatory agencies such as the Food 
and Drug administration (FDA) and European Medicines Agency (EMA) now routinely 
require screening of new compounds for potentially dangerous LQT-induced effects (Shah, 
2005). Anti-arrhythmic drugs are traditionally divided into four main classes, specific to 
their main target channel subtype. Na+ channel blockers are classified as type I, with Ia being 
less specific, and additionally prolonging APD through IKr block. Ib are more specific to 
the Na+ channel, and benefit from fast association and dissociation kinetics, shortening the 
AP but prolonging the post repolarisation refractory period (PRRP). Class Ic block Na+ 
channels with slower kinetics, mimicking functional loss of peak Na+ (Meregalli et al., 
2006), and do not affect APD. Class II are β-blockers, decreasing cardiac sympathetic input 
via β1-adrenergic receptors. Class III antiarrhythmics inhibit K+ channels (primarily IKr), 
causing APD prolongation and a reduction in the effective repolarisation period (ERP). Class 
IV compounds act on L-type Ca2+ channels, and are sometimes used for the treatment of AF. 
L-type blockers such as nifedipine cause APD shortening and decreased inotropic effects by 
lowering [Ca2+]i (Grunnet, 2010). 
A drug is considered QT-prolongating when either a QT interval of 500 ms or above is 
reached, or if it causes an increase of 60-70 ms from baseline, the latter accounting for 
naturally short-QT individuals. 
A common feature shared by TdP-inducing drugs is hERG channel blockade. Curiously, 
hERG blockade and QT-prolongation alone are not good predictors of TdP incidence. It is 
posited that the disparity in compound metabolisation in the body could explain, in part, why 
certain drugs perform unpredictably in vivo (Niemeijer et al., 2015). It is likely that 
compounds with a low potency for hERG blockade may not reach high enough plasma levels 
for comparable degrees of hERG blockade in vitro or in silico, such as terfenadine or 
astemizole (Schwartz, 2016). In contrast, certain concomitant conditions like impaired 
metabolism may exacerbate TdP with ordinarily safe compounds. To underline this, patients 
with a long history of treatment with a particular hERG blocker only developed TdP 
following a change in their medical condition, like reduced renal excretion (Anderson and 
Prystowsky, 1999; Reiffel and Appel, 2001). Patient-specific risk assessment must therefore 
be carried out on a case-by-case basis, and be an integral part of the treatment process. 
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1.6 Methods of study for electrophysiology 
Difficulties in screening and preventing TdP, as well as other lethal arrhythmias, drive the 
search for understanding the mechanisms underlying tissue electrophysiology. Studying 
whole heart electrophysiology requires a systems-level approach: from a single ion 
pump/channel to the whole cell, from a cardiac region to the whole ventricle, and how this 
coordinated electrical stimulation and calcium release triggers contractile proteins and 
finally generates blood flow through the heart chambers, to the body. Studying each aspect 
in isolation has proved problematic, as computer models often fail to accurately replicate 
what is observed in vivo. Such models routinely make assumptions of tissue homogeneity, 
either constrained by a ceiling in computational power, or simply because experimental data 
(i.e. cellular variation) is missing (Ponnaluri et al., 2016). Various methods used to study 
cardiac electrophysiology are discussed below, outlining advantages and limitations or 
current techniques, incorporating the work carried out in this thesis and its relevance the 
field. 
1.6.1 Action potential mathematical modelling 
In 1952, Hodgkin and Huxley studied electrical current flow through the membrane of the 
giant squid axon. Its unusually large diameter (typically 0.5 mm) constituted a convenient 
medium for electrophysiological study. Using a capillary threaded into the axon with an 
additional wire, they performed voltage clamp experiments, which led to the formulation of 
the now famous Hodgkin-Huxley model (Hodgkin and Huxley, 1952). Composed of just 
three currents (K+, Na+, leak (other ions)), it allowed them to predict the shape of action 
potentials with striking accuracy. This work pioneered the field of electrophysiology and 
earned both the Nobel Prize in Physiology and Medicine in 1963. Based on this seminal 
model, many mathematical models have been developed to describe action potentials in 
cardiac cells, tissues and species. These models are comprised of a set of nonlinear 
differential equations for voltage and a set of gating variables and ionic concentrations. The 
list of available models is steadily growing, each building on previous iterations of itself or 
using other models to improve predictive power and fidelity to experimental data (Shannon 
et al., 2004; Mahajan et al., 2008; Grandi, Pasqualini and Bers, 2010; O’Hara et al., 2011; 
Gong and Sobie, 2018). 
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1.6.2 Patch clamp 
Patch-clamping excitable cells or tissue using a glass micropipette is considered the gold 
standard measurement of cellular electrophysiology. Another joint Nobel Prize in 
Physiology or Medicine was awarded to Erwin Neher and Bert Sakmann in 1991 for 
developing this technique (Neher & Sakmann, 1976) . Patch clamp allows the direct 
recording of the electrical potential inside the cell, by applying gentle suction via a 
mouthpiece connected to a blunt glass micropipette. Several variations of the technique have 
been developed to record on-cell, whole cell, as well as inside-out and outside-out 
transmembrane membrane potential (Richardson and Xiao, 2010). Patch clamp allows for 
the study of individual cell action potentials in response to stimuli (e.g. drugs) through 
sequential changes in bath solutions; however, it is terminal, and the cell cannot survive the 
measurement, narrowing protocol complexity and limiting throughput. 
Three main aspects render this technique particularly difficult. Firstly, experimental 
experience is indispensable to success. While the precision of the equipment used does play 
a part, careful application of pressure to the cell, and the precise amount of suction is 
challenging. Successfully forming a tight seal (giga-ohm seal) with the cell membrane is a 
challenging task (Scanziani and Häusser, 2009). Maintaining a seal with the membrane also 
presents a challenge. Unwanted vibration and movement of the glass micropipette can cause 
leakage between glass and membrane, or tear into the cell entirely, which allows calcium to 
flow inwards and hypercontracts the cell. The electrical resistance of the micropipette, a 
critical aspect for successfully achieving a seal with the cell membrane, is a function of its 
manufacture. The protocols used to achieve the desired micropipette properties (e.g. tip 
diameter and sharpness) rely on heating and pulling a thin glass tube with both accuracy and 
consistency. Glass micropipette resistance can notably be influenced by the material 
properties of the glass, ambient temperature and humidity. Finally, the quality and fragility 
of the cell membranes on the day of cellular isolation can negatively impact the quality of 
the seal, and consequently further reduce throughput. The combination of the above factors 
has contributed to patch clamping being regarded as much of an art as a science, given its 
capricious nature. 
1.6.3 Optical methods 
While patch clamping cells yields excellent quantitative measurements of electrical potential 
across the cell membrane at a high temporal resolution (up to 50kHz), it is a difficult 
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technique to implement, even with experience and skill. Seasoned electrophysiologists will 
successfully patch no more than 10 cells per individual heart. This poses a problem, as it 
further reduces the experimental yield, already jeopardized by variations in cell viability due 
to enzymatic digestion. The use of less invasive techniques, like fluorescent dyes, to measure 
intracellular processes has capitalised on this. These cellular dyes are designed to change 
their fluorescent properties following specific processes (i.e. changes in membrane voltage 
(Vm) and [Ca
2+]i). They currently provide excellent spatial and temporal resolution from the 
whole heart (i.e. epicardial surface) to individual cells (neurons, cardiomyocytes) to 
organelles (e.g. SR-specific). 
Voltage-dyes can be broadly separated into two main categories, fast- and slow-response. 
While slow-response dyes, based on voltage-dependent accumulation can benefit from large 
relative increases in brightness to changes in membrane potential ( up to 80%∆F/F per 100 
mV), (González and Tsien, 1997), the drawback is their slow response time, due to their 
reliance on the redistribution of the dye within the lipid membranes, much slower than 
certain cellular events such as fast Na+ entry into cells (Miller, 2016).  
Commonly used probes sensitive to fast voltage changes include the ANEP dyes developed 
by the Loew group (Fluhler, Burnham and Loew, 1985), such as di-4-ANEPPS and di-8-
ANEPPS (Matiukas et al., 2006). Dyes with high fluorescent response per mV coupled with 
fast response entail certain caveats. Cytotoxic effects, from either the molecule itself, or ROS 
generation following exposure to light are a common limitation to their use (Schaffer et al., 
1994; Herron et al. 2012). Through ongoing innovation, fluorescent dyes have improved 
over the past decade. The search for fast and bright voltage-sensitive dyes led to the recent 
development of VoltageFluor dyes (Miller et al., 2012). Their basic mechanism uses 
photoinduced electron transfer (PeT) (Li 2007) as a direct competitor with fluorescence 
emitted by the molecule. The interaction between an electron donor and acceptor linked by 
a molecular wire is highly localised (in the order of nanometres). Consequently, the change 
in observed fluorescence following changes in Vm is extremely fast, and lends itself to 
resolving fast physiological events such as action potential upstroke, occurring in the 
millisecond range. 
The proprietary voltage sensitive dye FluoVolt (Thermo Fisher Scientific) was primarily 
investigated and used in this thesis. Minimising cell toxicity, while achieving a high signal-
to-noise ratio was one of the primary aims to optimise fluorescent measurements recorded 
for this work. 
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Calcium-sensitive molecular probes such as Fura-4F and Fluo-4 have been used for several 
decades (Bootman et al., 2013). Much like other fluorescent molecules inserted in 
membranes (Indo- and Fluo- dyes), they alter their fluorescent properties in response to 
changes in cytosolic changes in [iCa
2+]. 
Using combinations of dyes in the same sample presents its own challenges. As the 
excitation and emission spectra of cellular dyes shift transiently with [Ca2+]i and/or Vm 
changes inside the cell, creating crosstalk (mutual distortion) between wavelength channels, 
separating each fluorescent signal from each other becomes critical. This is achieved through 
the selection of dye with non- or minimally overlapping spectra combined with optical filters 
allowing separation of signals, or through spectral deconvolution, a form of post-processing 
to retrieve individual signals from a compound light emission. While there are pros and cons 
associated with either method, combining fluorescent dyes is rarely ideal. Near-infrared 
(>700 nm) dyes have been developed to avoid interference with endogenous chromophores, 
and for deep tissue imaging, by shifting their spectra towards longer (red to infrared) 
wavelengths (Matiukas et al. 2006; Salama et al. 2005). Expanding the range of wavelengths 
used also addresses the issues arising with spectral overlap, by allowing more than one 
fluorophore to be used simultaneously in the same sample with minimal interference 
(Herron, Lee and Jalife, 2012). 
1.6.4 In silico methods 
Understanding arrhythmia demands a stratified approach to the respective functions, and 
interactions of cardiac tissue, cells, and proteins. Mathematical models have been 
extensively used toward the better understanding of electrophysiology, both in health and 
disease. Comprising a set of differential equations that describe the respective “states”, 
(probability of being open or closed) of known channels, currents and variables such as 
intracellular ionic concentrations, recent models aim to describe the cell behaviour and to 
simulate health and disease through iterative calibrations with new experimentally acquired 
datasets. 
While proving useful in specific cases, these models are intrinsically limited by the data on 
which they are based. This essentially confines the span of possible predictions made by a 
hypothetical model to a subset of the total physiological range. Data collection tends to 
summarise findings as the average cellular behaviour observed experimentally, which 
greatly limits, and arguably incapacitates models with regards to predictions of population 
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variation. This could explain the limitations currently encountered in drug development. The 
mechanisms responsible for disparate drug effects from within subject populations are still 
elusive, forcing groups to investigate entire populations of models  in order to build a more 
comprehensive picture of population response to stimuli (Britton et al., 2013). 
Mathematical models typically output a predicted value for a given set of input variables. If 
population variation becomes a factor of interest, the output must also be represented as a 
“spread” of output values in the predicted output space (Kannankeril et al., 2010). These 
notions led a number of groups to pioneer the investigation of population variation within 
individual hearts (Sobie, 2009; Britton et al., 2013; Muszkiewicz et al., 2016). 
Experimentally determining the discrete effect of each variable change is made challenging 
when several changes are taking place concurrently, and challenged further when they 
influence one another dynamically. The relative weighting certain parameters (i.e. INa, IKr, 
ICa-L) carry in each respective model can vary significantly, and potentially skew the 
predictions made depending on the model used (Sarkar, Christini and Sobie, 2012). A 
straightforward approach to testing this is to vary each input parameter one at a time, and 
record how the output (e.g. repolarisation) is affected by each. This essentially yields a 
measure of parameter sensitivity. Sensitivity analysis of specific parameters was used by 
Romero et al. on a human ventricular cell model, by varying one parameter at a time by 
±15% and ±30% from baseline, to investigate its involvement on arrhythmic risk (Romero 
et al., 2009). Providing a robust measure of APD variation in controls experimentally will 
increase the relevance of parameter expression ranges expressed in electrophysiological 
models.  
Going one step further, models assessing model-model variation provide insight into the 
respective strengths and weaknesses of each. The implicit goal of cellular models is first to 
replicate experimental findings and then to predict subsequent findings. As prediction 
variation in any single model can be high, it could be minimised by assessing populations of 
predictions from separate models. As the number of developed models grows each year, the 
need for standardisation emerges, and several groups are attempting to address this problem 
(Terkildsen et al., 2008; Cooper et al., 2011). 
It is clear there exist limitations to both modelling and experimental investigation of cardiac 
arrhythmia. A combined approach to minimize weaknesses inherent to each could therefore 
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improve the prospects of the field by creating better, more versatile models capable of 
making testable predictions using medium/high-throughput experimental methods. 
1.7 Aims 
The primary aim of this thesis was to develop a medium/high-throughput method to study 
electrophysiological variation and E-C coupling in cell populations of the rabbit left 
ventricle.  
Using this technique, the secondary aims were to carry out regional comparisons of cellular 
electrophysiology between healthy and MI hearts, and quantify cellular and animal variation. 
Lastly, assessment of ion channel blockade on cellular sub-regions of the heart using same-
heart cell populations. 
 
1.7.1 Specific aims 
1. Develop and refine a medium/high-throughput methodology to study 
electrophysiology and E-C coupling of isolated cell populations in the rabbit left 
ventricle. (Chapter 3) 
2. Rigorously quantify physiological heterogeneity across populations of ventricular 
myocytes. (Chapter 4 and 5) 
3. Measure and quantify heterogeneity in response to IKr and L-type Ca2+ channel 
blockade in populations from sub-regions of the rabbit left ventricle. (Chapter 6) 
4. Infer from data how ion transport mechanisms vary and co-vary across populations. 
(General discussion) 
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2 Chapter 2: General Methods 
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2.1 Animals 
Animals used in this work were male New Zealand White rabbits (2.5-3.5kg) sourced from 
Envigo (Huntingdon, UK). Following a seven day quarantine/acclimatisation period, 
animals used at the University of Glasgow were killed in accordance with the Home Office 
Guidelines of the Animals (Scientific Procedures) Act 1986. 
2.2 Coronary artery ligation procedure 
The coronary artery ligation technique was performed as previously described (Pye and 
Cobbe, 1996; Ng et al., 1998; McIntosh, Cobbe and Smith, 2000) The operative procedures 
and echocardiographic assessment of the animals was performed by senior technician 
Michael Dunne at the University of Glasgow. Rabbits (12 weeks old) were pre-medicated 
with 0.4 mL/kg intramuscular Hypnorm (0.315 mg/mL fenatyl citrate: 10 mg/mL fluanisone; 
Janssen Pharmaceutica, Beerse, Belgium) and given antibiotic prophylaxis with 100 mg 
intramuscular Ampifen (Mycofarm UK Ltd, Cambridge, UK). The marginal ear vein was 
cannulated, and anaesthesia induced using 0.25-0.5 mg/kg midazolam (Hypnovel; Roche, 
Basel, Switzerland). The animal was intubated, and anaesthesia was maintained with 1% 
halothane in a 1:1 ratio of oxygen to nitrous oxide, delivered by Harvard small animal 
ventilator. (Harvard Apparatus Ltd., Edenbridge, Kent, UK). Access to the heart was 
obtained by a left thoracotomy through the fourth intercostal space. The marginal branch of 
the left anterior descending (LAD) artery, supplying the left-ventricular wall, was identified 
and ligated mid-way between the atrioventricular groove and apex. This produces a 
homogeneous infarcted area comprising 40-50% of the left ventricle. A dose of 10mg/kg 
quinidine (Sigma-Aldrich Company Ltd., Poole, Dorset, UK) was administered 
prophylactically as an antiarrhythmic agent, but in approximately 30% of cases ventricular 
fibrillation occurred, requiring a 5-10J epicardial direct current shock to restore normal sinus 
rhythm. After ensuring the animal was stable, the thorax was closed, and animals were 
administered 20 mL intravenous saline to replace operative losses. Analgesia was 
administered (0.04% intramuscular buprenorphine hydrochloride; Reckit Benckiser 
Pharmaceuticals Inc, Richmond VA, USA) immediately following the operation and the 
next morning. During recovery the animals were monitored for signs of distress. Sham-
procedure animals underwent identical surgical procedures, with the exception of the 
coronary tie. 
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2.3 Physiological extracellular solutions 
2.4 Extracellular bath solution 
All work performed on isolated cardiomyocytes used Krebs solution as an incubating bath 
solution for experimentation. All chemicals were obtained from Sigma-Aldrich (Saint Louis; 
MO, USA) unless otherwise stated. 
2.4.1 Isolation medium 
130 mM NaCl, 4.5 mM KCl, 3.5 mM MgCl26H2O,0.4 mM NaH2PO4,5 mM HEPES, 10 mM 
glucose. Solution pH was adjusted to 7.25 at 37˚C using 1 M KOH. 
2.4.2 Krebs solution 
120 mM NaCl, 20 mM HEPES, 5.4 mM KCl, 0.52 mM NaH2PO4, 3.5 mM MgCl26H2O, 
20mM taurine, 10 mM creatine and 11.1.mM glucose hexahydrate. Solution pH was adjusted 
to 7.4 at 37˚C using 1 M NaOH. 
2.4.3 Kraft-Bruhe (KB) solution 
70 mM KOH, 40 mM KCl, 50 mM L-glutamic acid, 20 mM taurine, 20 mM KH2PO4, 3 mM 
MgCl26H2O, 10 mM glucose, 10 mM HEPES, 0.5 mM EGTA, pH 7.4 at 37˚C using 1 M 
KOH. 
2.4.4 Enzyme 
Collagenase enzyme (powder; Worthington Biochemical Corporation) was added to KB 
solution (217 IU/mL) and re-circulated through the perfusion system for ~5 minutes until 
the heart tissue began to moderately swell and lighten in colour. 
2.4.5 Langendorff and cardiomyocyte isolation 
All animal handling and procedures including surgical interventions and Langendorff 
procedures (see Figure 2.1) were carried out by laboratory technicians Aileen Rankine and 
Michael Dunne. Male New Zealand White rabbits (2.5-3kg) were euthanised with an 
intravenous (IV) injection of 0.5mL/kg Euthatal (200 mg/mL, Sodium pentobarbitone, 
Rhone Merieux Inc, Athens, GA, USA) mixed with 500IU of heparin (CP Pharmaceutical 
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Ltd, Wrexham, UK) via the left marginal ear vein. Once absence of pain reflexes was 
confirmed, hearts were quickly excised with ~0.5cm of the ascending aorta, and placed in 
ice-cold KB solution to inhibit muscle contraction. Prior to starting perfusion, the system 
was primed with KB solution to avoid air bubbles entering the system and potentially 
compromising heart muscle perfusion. Excess tissue was trimmed away and the heart was 
connected to a Langendorff system, and retrogradely perfused with calcium-free oxygenated 
KB (37°C) using a peristaltic pump at a constant flow rate of 20ml/min for 5 minutes 
(Skrzypiec-Spring et al., 2007; Bell, Mocanu and Yellon, 2011). The heart was then perfused 
with enzyme solution, which was collected and re-circulated. After 3 min, 100 mmol/L 
CaCl2 solution was added to achieve a final calcium concentration of 0.05 mmol/L. 
Digestion was continued for 5-6 minutes, until the heart began to soften to the touch and 
lighten in colour. The heart was perfused with KB solution containing a 10g/L bovine serum 
albumin (BSA) containing 0.075 mmol/L calcium. In infarcted hearts, the apex and a 3-5 
mm rim around the infarct zone were removed. This step removed a large portion of the scar 
tissue, and has also been shown to remove peri-infarct border zone myocytes (Burton, 
McPhaden and Cobbe, 2000). The equivalent apical region was removed in Sham animals. 
Perfusion was stopped and the heart was dissected. The ventricles were cut into ~1 mm2 
segments in BSA solution. Using fine forceps and scissors, both epicardial (epi) and 
endocardial (endo) regions were isolated by cutting sections ~1 mm deep into either side of 
the LV, excluding the mid-myocardial region. Basal and apical regions were obtained from 
top and bottom of the LV, with a separation of 1 cm along the longitudinal axis of the heart 
(see Figure 1.5). Tissue pieces were placed in a 15 mL culture flask and placed on a shaker 
for 20 min. Cells were gently triturated with a Pasteur pipette to further dissociate myocytes, 
and the supernatant was filtered through polyamide mesh (250 µm pore size) prior to 
resuspension in KB solution. 
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Figure 2.1 Diagram of Langendorff setup for cell isolation. Simplified diagram of 
Langendorff setup using peristaltic pump and water bath system for retro-perfusion of 
coronary arteries with enzyme solution at 37ᵒC. 
2.4.6 Cell preparation for experimentation 
Cells underwent serial incubations in Krebs solution baths containing increasing 
concentrations of Ca2+ (using 1 molar CaCl2). Cells were left to settle with gravity for 10min 
in 15mL Falcon tubes containing Krebs and increasing calcium concentrations: 100 µM, 300 
µM, 1 mM, and 1.8 mM CaCl2, respectively. Experiments were only performed on cells with 
clear striation and showing no signs of abnormal electrical behaviour, such as EADs, 
alternans, or irregular beats. 
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2.5 Optical apparatus setup 
 
Figure 2.2 Optical apparatus diagram. Simplified diagram of optical system used for 
fluorescence measurement of action potentials and calcium transients in isolated 
cardiomyocytes (CM). 
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Light from excitation LEDs (340nm, 380nm, or 470nm) excites the sample in the custom 
stage incubator (see Chapter 3). Emitted fluorescence is reflected from the sample onto a 45ᵒ 
585nm short-pass and a long-pass dichroic mirror to photomultiplier tubes. The light signal 
intensity, amplified via photo-multiplier tube, is converted to a voltage signal (Cairn 
Research Ltd). The output is then passed through an analog-to-digital converter (National 
Instruments UK), and displayed on the monitor using the CellOPTIQ program designed by 
Dr Francis Burton. 
2.5.1 CellOPTIQ 
The software used to control hardware, as well as perform trace analysis used in these 
fluorescence experiments was designed and written by Dr Francis Burton. The CellOPTIQ® 
platform was used throughout this work to collect fluorescent measurements from isolated 
cardiomyocytes loaded with fluorescent dyes. 
CellOPTIQ controlled the XY position of the bath system using a motorised stage, allowing 
cell locations to be saved for repeated measurements (e.g. before and after drug incubation). 
It also provided flexible control of the excitation LED protocol used for cellular dye 
excitation (see Chapter 3). Finally, CellOPTIQ was used to analyse fluorescent traces 
acquired for each cell, by averaging action potential and calcium transient trains. Descriptive 
values of action potentials and calcium transients were generated and exported to a summary 
table for statistical analyses. 
2.6 Fluorescence spectroscopy 
Optical dyes which display transient changes in fluorescence intensity at a fixed wavelength 
in response to changes in substrate availability (e.g. Vm, [Ca
2+]) are referred to as single 
wavelength. In contrast, ratiometric indicators change the shape of their excitation or 
emission spectra in response to changes in calcium concentration. Expressed as a ratio, their 
relative fluorescence measured at two different wavelengths provides a robust measure of 
substrate change without being negatively impacted by disparate dye loading, uneven 
illumination or movement (Wokosin, Loughrey and Smith, 2004). 
2.6.1 Voltage-sensitive dyes  
The dyes used in this study were selected based on their excitation emission spectra. The 
apparatus used has previously been optimised for di-4-ANEPPS, excited at 470 nm (see 
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Figure 2.3).  Di-4-ANEPPS has been widely used to monitor changes in membrane potential 
(Morad and Salama, 1979). While it was reported to yield ~7-10% ∆F/F per 100mV, di-4-
ANEPPS is rapidly internalized into cells, limiting its uses to short experiments (Herron, 
Lee and Jalife, 2012). The recording of membrane potential in adult cardiomyocytes in this 
work was achieved using established voltage-sensitive fluorescent dyes di-4-ANEPPS, and 
the more recently developed FluoVolt. 
 
Figure 2.3 Di-4-ANEPPS spectra. Excitation(black) /Emission (red) spectrum of di-4-
ANEPPS.  
As voltage potential increases inside the cell from a resting potential (e.g. from -85 mV to -
40 mV), di-4-ANEPPS emission peak shifts left toward shorter wavelengths. Measuring 
emitted light at two wavelength bands (dashed red lines at 550nm and 650nm, respectively.) 
consequently allows a quantitative measure of the membrane potential by calculating the 
fluorescence ratio of these emission bands. 
 
 
31 
 
2.6.2 FluoVolt excitation/emission spectra 
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Figure 2.4 FluoVolt Spectra. Excitation-emission spectra of FluoVolt®. Excitation peak is at 
522nm, with peak emission at 536nm. Also displayed for reference are the excitation 
wavelengths used for both voltage (470nm) and calcium (340nm/380nm) in this thesis.  
The excitation-emission spectrum of the FluoVolt molecule has not been made publicly 
available. Using a spectrophotometer (LS 50b, Perkin-Elmer), the FluoVolt excitation and 
emission spectra were determined (see Figure 2.4). Transparent cuvettes (1.5 mL) were filled 
with FluoVolt-loaded cell suspension in Krebs solution. Background fluorescence was 
assessed using a dye-free cell suspension. Using a 15 nm slit width, combined with a 150 
nm.min-1 scan speed produced the most detailed spectra, free of signal saturation. All spectra 
shown in this work were background-subtracted, eliminating the contribution from cell 
membrane autofluorescence. The same excitation wavelength (470nm) as that used to excite 
di-4-ANEPPS was used with FluoVolt, as the resultant emission signal brightness was 
satisfactory, and consequently did not require modifications to be made to the experimental 
apparatus. 
While information about the FluoVolt molecule is still proprietary, Woodford et al. (2015) 
describe voltage-sensitive molecules (VoltageFluor dyes) with strikingly similar Ex/Em 
peaks to what we found for FluoVolt. One molecule, VF2.1.Cl (see Figure 2.5), is the best 
fit with reported peaks at 522nm/536nm, and a reported ∆F/F of 27% per 100mV. 
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Figure 2.5 VF2.1.Cl molecule. Proposed FluoVolt molecular structure from literature 
(Woodford et al. 2015). 
2.6.3 Intracellular calcium ion indicators 
Calcium ion (Ca2+) indicators are molecules based on the structure of a Ca2+ chelator 
(BAPTA) and allow the measurement of calcium transients via a change in the intensity or 
wavelength of the emitted light (Grynkiewicz, Poenie and Tsien, 1985). 
The following work used Fura-4F, in its acetoxymethyl (AM) ester form (Life technologies, 
Thermo Fisher Scientific; Waltham, MA USA). The AM modification allows Fura-4F to 
permeate cellular membranes. The lipophilic groups tail is cleaved by non-specific esterases 
intracellularly, leaving a charged form of the dye which exits the cell at a slower rate than 
the non-AM form (Grynkiewicz, Poenie and Tsien, 1985). Fura-4F alters its excitation 
spectrum when bound to calcium (see Figure 2.6). The bound form has an excitation peak at 
380 nm, contrasting 340 nm for the unbound form. Fura-4F(AM) was consequently excited 
at these two different wavelengths in rapid succession (340 nm and 380 nm, respectively) 
using LEDs. The emission fluorescence was recorded at a single wavelength band (>585 
nm) and expressed as a ratio of the two resulting signals. Following precise calibration of 
dye fluorescence relative to local presence of Ca2+ in solution (see Chapter 3), accurate Ca2+ 
measurements could be made in live single cells at a temporal resolution of 2 ms (500Hz 
sampling rate). 
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Figure 2.6 Excitation spectrum of Fura-2 overlaid at 10 incremental concentrations of Ca2+ 
(0-39 µM). It is identical to Fura-4F and consequently excitation wavelengths used in these 
experiments are outlined at 340 nm and 380 nm (dotted lines). The isosbestic point (360 
nm) denotes where emission intensity at 510nm is not a function of [Ca2+], and remains 
constant at any concentration. Figure taken from (Bioquest, 2018). 
2.6.4 Dye loading protocols for isolated CMs 
2.6.4.1 Di-4-ANEPPS loading procedure 
Cells were incubated for 1 min in 6 µM di-4-ANEPPS, then gently centrifuged to form a 
loose pellet and resuspended in 1.8mM Ca2+ Krebs solution. 1mL cell suspension was added 
to 1 mL of clear Krebs to a 35mm, glass-bottomed dish (MatTek, 35 mm, 14 mm microwell). 
2.6.4.2 FluoVolt cell-loading procedure 
The FluoVolt (Thermo Fisher) molecule size and molar mass is not currently available in 
literature due to commercial restrictions. Concentrations used are expressed as µl of 
FluoVolt dye per mL of Krebs solution. Manufacturer recommendation is 1:1000 (1 µl.mL-
1) for 25 min at room temperature (RT). As described later, initial experiments used 
manufacturer-recommended protocols, however these were altered following optimisation. 
Optimised protocols used 1 µl in 6 mL Krebs, resuspending cells halfway through the 25min 
incubation period. After settling down, the supernatant was removed, and cells were 
resuspended in clear Krebs. 1 mL cell suspension was added to 1 mL Krebs in a 35mm dish. 
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2.6.4.3 Fura-4F loading procedure 
Unless stated otherwise, a stock solution of 2 mM Fura-4F(AM) was prepared by dissolving 
50 µg Fura-4F(AM) in 25 µl anhydrous dimethylsulphoxide (DMSO), stored at 4ᵒC. For cell 
loading, 15 µl of the stock was added to 5 mL Krebs (1.8mM CaCl2) solution for a final 
concentration of 6 µM, in which cells were incubated at RT for 20 min, and resuspended 
after 10 min to promote dye interaction with cells, and for Fura-4F(AM) to undergo de-
esterification. The supernatant was removed, and cells were resuspended in clear Krebs 
solution. 1 mL cell suspension was added to 1 mL of clear Krebs to a 35 mm dish and cells 
could settle onto the glass. 
2.6.4.4 Pluronic acid (F-127) 
Emulsification of Fura-4F(AM) was facilitated using 20%(w/v) pluronic acid (F-127, in 
100% DMSO). Pluronic acid facilitates the solubilisation of water-insoluble dyes in cellular 
media by breaking up droplets of dye and coating them in polar globules, promoting dye 
delivery into polar membranes. Pluronic acid was later added directly to Fura-4F powder (25 
µg) up to 2mM stock, to further minimise cell exposure to DMSO. The use of pluronic acid 
improved cell loading of AM dyes, whereby all cells loaded with the pluronic-AM dye 
solution produced fluorescent signals, which was not the case when using Fura-4F(AM) 
alone. 
2.6.4.5 Dual-loading with Fura-4F(AM) and FluoVolt dyes 
Pluronic acid F-127 (20% in DMSO, Thermo Fisher Scientific) was heated gently to 
decrease its high RT viscosity. Fura-4F(AM) powder (50 µg) was dissolved into 20% 
Pluronic acid F-127 (in DMSO) to the desired concentration and thoroughly vortexed in a 
0.5 mL Eppendorf. FluoVolt (1 µl) was added to 3 µl of Fura-4F-AM/Pluronic mix and 
vortexed again until the colour turned to homogeneous orange. This mixture was added to 
6mL of Krebs (1.8mM CaCl2) to achieve a 1:6000 concentration of FluoVolt and 1 µM Fura-
4F(AM) concentration. Cells were incubated in this solution for 25min at RT and 
resuspended halfway, identically to other dye-loading protocols. 
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2.6.5 Excitation-Contraction (E-C) uncoupling 
2.6.5.1 E-C uncouplers 
E-C uncouplers are commonly used in cardiac optical mapping/conduction experiments for 
suppression of motion artefact. The primary action of these is to suppress and inhibit muscle 
contraction without altering electrical activity across the myocardium. Several compounds 
are available including cytochalasin D (Cyto D), 2,3-butanedione monoxime (BDM) and 
more recently blebbistatin. BDM is non-specific, and is known to affect SERCA2 activity, 
limiting its usefulness (Herron, Lee and Jalife, 2012). Conversely, blebbistatin is specific to 
myosin II , inhibiting adenosine triphosphatases (ATPases) in an actin-detached state 
(Kovács et al., 2004; Allingham, Smith and Rayment, 2005; Fedorov et al., 2007). Its 
behaviour in this unbound state is advantageous because it prevents any stiffness which may 
result from a constant actin-myosin crosslink. Additionally, it has been extensively used in 
zebrafish, mouse, rabbit, human, and several other species.(Jou et al. 2010; Dou et al. 2007; 
Mironov et al. 2008; Fedorov et al. 2010). While blebbistatin has been reported not to cause 
noticeable effects on cardiac electrophysiology in the past (Fedorov et al., 2007), it has more 
recently been shown to have some minor effects on ECG parameters and atrial and 
ventricular electrophysiology. Additionally, a recent study suggests that blebbistatin may 
have adverse effects in whole heart rabbit experiments, including APD prolongation and 
reduced VF threshold (Brack et al., 2013). These effects are minimal compared with other 
E-C uncouplers (e.g. BDM) (Lou, Li and Efimov, 2011). 
Another more serious disadvantage to using blebbistatin is its photosensitivity and 
phototoxicity. Studies have shown that both UV and blue light photo–inactivate blebbistatin, 
resulting in toxicity from the production of free radicals, causing oxidative damage locally 
(Kolega, 2004; Sakamoto et al., 2005). This E-C uncoupler was used exclusively for testing 
the contribution of movement to fluorescent traces in contracting single cells, and not for 
any physiologically relevant phenomena. While investigating the impact of motion artefact 
on fluorescence recordings, cells were incubated in blebbistatin solution (3 µM, for 25 min). 
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2.6.6 Fluorescence recordings 
2.6.6.1 Lens aperture and light collection 
The amount of light collectable by a microscope objective is expressed as numerical 
aperture (NA). Numerical aperture is a measure of the broadness of the light cone from the 
focused sample able to enter and diffract through the front lens. NA is the product of the 
refractive index of the medium through which the sample is observed (e.g. air, oil) and the 
maximum angle of light entering the lens with the sample in focus (Equation 1). 
𝑵𝑨 = 𝒏. 𝒔𝒊𝒏𝜽 
Equation 1 Numerical aperture equation. Equation for Numerical aperture, where n is the 
refractory index of the medium between the objective and the sample (air = 1.00) and 𝜃 
denotes half the maximum angle of light entering the objective with the sample in focus. 
The visual field brightness (B) of the microscope is proportional to both the numerical 
aperture and the magnification of the objective used (Equation 2). The maximum NA 
available for air objectives is 0.95. Water- or oil-immersed objectives are required to further 
increase light collection efficiency, by increasing the refractory index of the medium 
between the objective and the sample. Figure 2.7 shows a comparison of light collection 
between two objectives. The higher NA (0.95) objective was used throughout this thesis. 
B ∝
𝑵𝑨𝟐
𝑴𝟐
 
Equation 2 Relationship of brightness index respective to aperture and magnification. 
Brightness index equation, demonstrating increased aperture or decreased magnification 
increases overall brightness.  
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2.6.6.2 Selection of optics 
 
Figure 2.7 Light collection efficiency of high NA lens. Fluorescein signal (a.u.) with 
incremental dilutions was compared between two 40X objectives (UPlanSApo, cat no. 
AMEP4754). Under identical 470 nm illumination, the high aperture objective (red; NA 
0.95) collects over 3 times more light than the lower aperture objective (blue; NA 0.6) at all 
dilutions tested. Typical signal intensity encountered experimentally shown in grey. 
As shown in Figure 2.7, solutions of serially diluted fluorescein (1, 1/2, 1/4, 1/8, 1/16) were 
used to compare light-collection efficiency between two objectives of identical 
magnification. The highest concentration of fluorescein was selected close to the saturation 
point of the light-sensing apparatus to compare each lens over the full range of the signals 
typically encountered experimentally. Using higher NA objectives allowed lower 
concentrations of fluorophores to be used, along with lower excitation power, in turn 
resulting in less photodamage and cytotoxic effects for a given signal-to-noise ratio (SNR). 
See section 3.6.2 for lens selection rationale. 
2.6.6.3 Voltage recordings 
Following excitation at 470 nm wavelength, fluorescent signals emitted by voltage-sensitive 
dyes (di-4-ANEPPS and FluoVolt) were respectively sampled above 585 nm at 10 kHz with 
photo-multiplier tubes (PMTs). This sampling rate is very high and allows sub-millisecond 
temporal resolution of voltage changes (dye response being in the µs range), provided 
subsequent trace filtering is chosen appropriately. This was essential to accurately capture 
the upstroke of the ventricular action potential, which routinely occurs in the range 1-4 ms. 
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2.6.6.4 Calcium recordings 
The calcium-sensitive dye Fura-4F(AM) was excited alternately at 340 nm and 380 nm, and 
the resulting emissions at 510 nm recorded using a PMT as described above. The sampling 
rate for Ca2+ fluorescence was 500 Hz, allowing a 2 ms temporal resolution of Ca2+ kinetics 
inside the cell. The reason for this 20-fold lower rate compared to voltage is to allow for 
sequential excitation of the fluorophore at each wavelength without causing cross-excitation 
(See Figure 2.8).  
 
Figure 2.8 Fura-4F dual-wavelength excitation protocol. Excitation protocol for Fura-
4F(AM). 340m LED is switched on for 1 ms, immediately switched off as the 380nm LED 
is switched on for 1 ms. The resulting ratio can consequently be sampled at a maximum 
resolution of 1 point every 2ms (500Hz).  
While excitation occurred for a duration of 1ms, signal was recorded in the last 0.5 ms 
interval to allow the LED to reach steady state. 
2.6.6.5 Simultaneous voltage and calcium recordings 
A new excitation protocol was devised for cells loaded with both voltage- and calcium-
sensitive dyes (FluoVolt and Fura-4F(AM)). Excitation at each wavelength (i.e. 470 nm, 340 
nm, 380 nm) was achieved sequentially. Obtaining voltage and calcium information nearly 
simultaneously constrained the sampling rate of each recording. Triple-excitation traces 
were recorded at 333Hz, recording a fluorescence value every 3ms for all three channels, 
respectively (see Figure 2.9). 
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Figure 2.9 Triple excitation protocol. Triple excitation LED protocol for Fura-4F and 
FluoVolt. Each LED (470 nm, 340 nm, 380 nm) is turned on for 1 ms and off for 2 ms in 
immediate succession. This excitation protocol reduces the maximum temporal resolution 
to 333 Hz. 
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2.6.6.6 Fluorescent signal analysis: Voltage and Calcium 
Trace analysis was conducted using CellOPTIQ software. The raw, unfiltered trace was 
baseline-subtracted (fitting and subtracting an exponential decay), filtered using 3-point, 15 
pass filter (moving 3-point average, applied 15 times). This was the lowest level of filtering 
possible without compromising measurements of the AP upstroke (See Figure 4.3). The 
upstroke and repolarisation phases were filtered adaptively to a target smoothness, measured 
by the number of curve inflections. A 3-point boxcar was used as it is the smallest 
symmetrical odd number (5, 7…etc could also be used). Averaging points on either side of 
each point preserved the time-base (i.e. an average of only 2 adjacent points would 
artificially create a value in time in between them). The number of passes of the boxcar for 
all experiments (15) was selected as it was the minimum filtering required for the vast 
majority of signals to be analysable. Lastly, applying incrementally larger boxcars repeatedly 
is quickly outperformed computationally by applying a small 3-point average iteratively. 
Values used in analysis were TRise (upstroke time from 10% to 90% depolarisation), and 
APD30,50,90 values, representing time (ms) from upstroke to several degrees of repolarisation. 
 
Figure 2.10 Action potential recorded parameters. Example of averaged action potential 
labelled with main variables recorded. TRise was measured from 10% depolarised to 90% 
depolarisation of maximal amplitude. APD values (e.g. APD90) represent time from 
upstroke to % repolarisation from peak fluorescence. 
To describe the general shape of phase 3 (repolarisation phase), an index of triangulation 
was calculated using an early (APD30) and a late (APD90) repolarisation metric (see Figure 
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2.10). This index was normalised for AP duration as follows: Triangulation index = 
𝐴𝑃𝐷90−𝐴𝑃𝐷30
𝐴𝑃𝐷90
, demonstrated in Figure 2.11. 
This index is commonly seen in literature, generally expressed as the difference between 
APD90 and APD30 in ms (Hondeghem, Carlsson and Duker, 2001; Grunnet, 2010; Trenor et 
al., 2013; Zhu et al., 2016). Not accounting for action potential duration can, however, be 
misleading, and while this method is appropriate for comparing the shape of action potentials 
with similar APD90, it quickly fails with relatively small differences in duration, over-
reporting triangulation in long APs and equally under-reporting triangulation in short APs. 
In this way, normalising the index for APD ensures it remains sensitive to changes in shape, 
irrespective of duration. Some groups do report APD-corrected triangulation (Blinova et al., 
2018), however there is a need for standardisation of this index, frequently used to describe 
the arrhythmogenicity of AP wave-forms. 
 
Figure 2.11 Diagram of AP triangulation case. Diagram of two action potentials with 
identical APD90 values. The black trace has a low triangulation index compared to the 
dashed red AP. The index provides information about the degree of plateau present, 
normalised for APD. 
Calcium traces were subjected to the same process as described above, 340nm and 380nm 
traces expressed as a ratio 
340𝑛𝑚
380𝑛𝑚
. Values extracted from this analysis were baseline, TRise, 
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amplitude, and CD values (calcium decay), representing decay of calcium following 
contraction, in percentage from maximum (see Figure 2.12). 
 
Figure 2.12 Calcium transient recorded parameters. Example of an averaged calcium 
transient labelled with variables of interest. Baseline denotes “resting” diastolic Ca2+. Peak 
is the maximum fluorescence value, or systolic calcium peak. TRise describes time (ms) 
from baseline to maximal Ca2+. CD values time to 10,50,90% Ca2+ decay. 
2.6.6.7 Analysis of cell contraction using ImageJ 
Contraction measurement in cardiomyocytes was achieved using sarcomere length 
measurement. High-speed (100 fps), high resolution (2048x2048 pixel) video was recorded 
using a Hamamatsu camera and a 40X, 0.95 NA objective (Inverted Olympus microscope). 
Image sampling durations were chosen to allow a minimum of 5 beats to be recorded and 
subsequently averaged for analysis, at all pacing frequencies. 
Using the macro SarcomereLength created in ImageJ by Dr Francis Burton, each stack of 
images (typically 500) was analysed by manually placing a linear selection perpendicular to 
the cell sarcomeres, to capture the cleanest isotropic contraction possible. Line length was 
controlled by the operator and varied depending on cell size (minimum of 100 pixels). Line 
width was kept constant at 50 pixels, reducing influence of pixel noise by averaging pixels 
across the width (see Figure 2.14). 
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2.6.6.8 Sarcomere length analysis 
 
Figure 2.13 Contraction profile recorded parameters. Example train of 3 contractions listing 
variables recorded for contraction analysis. L0 Mean distance between sarcomeres in the 
cell at maximal relaxation (µm). Amplitude Extent of sarcomere shortening (expressed as 
µm or % relative to peak). CD10 Duration from 90% contraction to 10% relaxation (ms). 
TRise Time from 10% contraction to 90% (ms). Dn90 Time from 90% contraction to 90% 
relaxation (ms). 
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Figure 2.14 Measurement of sarcomere length. Diagram showing cell contraction analysis. 
(a) Shows a cardiomyocyte and the line placement perpendicular to the sarcomeres. (b) 
Shows the 5 second trace generated using the ImageJ plugin. (c) Table of contraction 
kinetics values derived from the plotted trace. The mean kinetics of 5 contractions was 
collected for data analysis. 
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2.6.6.9 Calibrating intracellular calcium using ratiometric dye Fura-4F (AM) 
Using the ratiometric properties of Fura-4F, the absolute concentration of calcium in cells 
can be calculated by calibrating the dye fluorescence at both excitation wavelengths (340 
nm and 380 nm, respectively), expressed as a ratio. To measure absolute intracellular [Ca2+], 
a calibration curve was generated using precise concentrations of free calcium ions ranging 
from nM to mM. By knowing the dissociation constant of Fura-4F (Kd), as well as the ratio 
value for maximum and minimum fluorescence emitted by the dye in presence of 0 mM Ca2+ 
and 10 mM Ca2+, the absolute calcium concentration inside the cell can be calculated 
(Equation 3).  
The Kd value is dependent on excitation and sampling efficiency of Fura-4F fluorescence 
(i.e. LED power, excitation range (nm)). For that reason, it is sensitive to different optical 
setups and consequently is specific to the optical setup it is measured by. 
2.6.7 Optical system Kd calculation 
Three solutions containing 20 µM of the calcium ionophore calcimycin (A23187) were 
prepared. RMIN solution contained 5 mM EDTA. RMID solution contained EDTA and 
CaEDTA at a 1:1 ratio, and RMAX solution contained 10 mM CaEDTA. 
To calculate the free calcium present in solution based on these solutions, the free-calcium 
calculator REACT was used (Smith, 1983). 
[𝐶𝑎2+] = 𝐾𝑑 ∗ 𝛽 ∗
(𝑅 − 𝑅min )
(𝑅𝑚𝑎𝑥 − 𝑅)
 
Equation 3 Kd equation. Calibration equation for calcium concentration as a function of 
fluorescence recorded from the sample at 3 points (Rmin, Rmid, Rmax). (Equation from 
(Grynkiewicz, Poenie and Tsien, 1985) 
Adult CMs were isolated and remained in KB solution (0 mM Ca2+) at 37ᵒC. Cells were 
seeded at low density onto 35 mm MatTek dishes and left to settle. The background 
fluorescence was recorded by shaping a rectangular iris to fit the cell, and recording the Fura-
4F ratio of the area immediately next to it. The cell was then illuminated with the 340 nm/380 
nm excitation protocol previously described. Half the volume (1 mL) of the dish was 
removed and replaced with a 2X RMID solution. The same protocol was applied for RMAX, 
with a final concentration of calcium of 10 mM. 
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Figure 2.15 Fura-4F fluorescence vs. [Ca2+]. Background-subtracted fluorescence ratio (340 
nm/380 nm) of Fura-4F at three known calcium concentrations. (Rmin = ~20nM; Rmid = 
420nM; Rmax = 10mM). Kd estimate shown by dotted lines.  
The relationship between calcium concentration inside the cell and the ratio of emitted light 
from Fura-4F at 340nm and 380nm excitation is shown in Figure 2.15. Using the midpoint 
ratio along the sigmoidal relationship, the Kd was found to be 177 µM. This value is however 
likely to be a product of the 𝛽 value (system-specific) and the Kd of Fura-4F. More work is 
required to calculate the absolute calcium concentration in cells using ratiometric Fura-4F 
measurements, however the kinetics of calcium transients recorded are unaffected by this. 
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2.6.8 Statistical analyses 
2.6.8.1 Standard statistical tools 
Data are presented as mean ± standard error of the mean (SEM) unless otherwise stated. 
Statistical analyses were performed using GraphPad Prism 7. Single comparison of means 
was conducted using standard 2-tailed t-test (paired where appropriate). For parametric data, 
one-way ANOVA followed by multiple comparison tests were used to compare three or 
more groups of data. For non-parametric, independent datasets, Mann-Whitney U test was 
used. All tests were set at a significance threshold of P<0.05. (Significance stars: *, **, *** 
denote a p-value less than or equal to 0.05, 0.01, and 0.001, respectively).  
2.6.8.2 Hierarchical Statistics 
The statistical approaches listed above assume independence in datasets and ignore potential 
clustering of datasets, however when comparing two populations of cells within the same 
heart (e.g. endocardium and epicardium), these regions may well be more similar to one 
another than to another animal’s, and consequently cannot be considered independent. This 
concept of data clustering requires higher-level analysis, considering both the data clustering 
present within sets, but also the size of each set relative to the total sample size, to avoid 
skewing the results towards the set with the highest number of measurements. Sikkel et al. 
(Sikkel et al., 2017)have demonstrated that in multi-level datasets, and more specifically 
isolated CM studies, improper statistical approaches can lead to false-positive results, as well 
as abnormally small P values to be reported. Conversely, false negatives can and do occur 
just as easily (i.e. when the difference between sets is overshadowed by the intrinsic variation 
in higher level sets.). 
For example, Coulibaly, Chen-Izu and Izu, (2017) have outlined the issue of over-estimating 
experimental N-numbers, by counting multiple measurements from the same heart as 
independent. To illustrate this point, they use the example of three rats, each of which 
provides 10 measurements of blood glucose (see Figure 2.16). To describe the mean rat 
population blood glucose, we should use n = 3, and not n = 30, as each group of 10 
measurements only describes variation within one animal. 
In this context it is quite clear that the number of measurements taken from each rat, no 
matter how large, can only give a better estimation of this specific animal’s blood glucose, 
and not be counted toward the total population mean as more than one measurement. By 
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increasing the sample size of each animal, the standard error of the mean of the whole 
population would tend to zero, artificially increasing the probability of statistical difference 
with another group. 
In the context of AP duration in a population of cells from specific subregions of the same 
ventricle, increasing sample size does cause a reduction of the SEM, but additionally (i) 
allows better estimation of the true mean of the population and (ii) provides a representative 
measure of the variation present between cells. 
 
Figure 2.16 Illustrative example of clustered datasets Hypothetical distribution of glucose 
concentrations in three rats (red, green and blue curves) and of the population. (Figure 
taken from Coulibaly et al. 2017) 
In this thesis, hierarchical testing was used to assess the statistical differences between 
clustered sets (cells originating from different regions of the same heart) using published 
code written in R (Sikkel et al., 2017). Sikkel et al. propose a hierarchical analysis of 
clustered datasets as a significant improvement over conventional approaches, shown by the 
χ2-2LL (deviance) criterion (i.e. provides a superior description of the data than t-test or 
ANOVA). The hierarchical test is compared to the “common test”, which assumes data 
collected from each animal is independent (i.e. endocardial cells considered independent 
from epicardial cells within the same heart), and determines whether the latter better fits the 
data using χ2-2LL. Once it has been established the data is clustered in nature, the p-values 
generated by comparisons of pairs of variables (e.g. endocardium vs epicardium) are 
multiplied by the number of comparisons (animals) per dependent variable. A comparison-
weighted p-value is then generated, more accurately representing the difference present 
between compared sets. (Code available in Appendix, p139) 
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3 Chapter 3: Development of a medium-
throughput, optical voltage and calcium 
measurement technique 
  
 
 
50 
 
3.1 Background 
Increasing sample size per experiment is highly sought-after in the field of single-cell 
electrophysiology. Current methods yield high-quality measurements, but lack efficiency in 
their use of resources, especially animals and time. Studying isolated cardiomyocyte 
populations from individual animals is problematic. Firstly, cellular isolation via enzyme 
dissociation is widely known to be both challenging and unpredictable (Louch, Sheehan and 
Wolska, 2011). Isolation of cardiomyocytes from cardiac tissue was developed over 40 years 
ago (Powel and Twist, 1976). It allowed the study of cell mechanics, electrophysiology, 
calcium dynamics, along with various staining techniques (IHC, protein biochemistry) to be 
applied to isolated cardiomyocytes from various species. The main motive for developing a 
technique to isolate cardiomyocytes was the impractical nature of tissue preparations for 
voltage clamping experiments (Louch, Sheehan and Wolska, 2011). Single cells allowed 
complete control over the membrane potential, and additionally permitted the study of cells 
deep in the myocardium which were then optically out of reach (e.g. mid-myocardial cells). 
A major limitation of enzymatic dissociation is membrane damage. Cells are highly sensitive 
to contaminants during the dissociation process, which increases the danger of membrane 
perforation and leakage. Regulation of age/weight of the animal, solution pH and 
temperature, as well as the batch of collagenase enzyme used are also variables to be 
considered and controlled for a successful cell isolation (Kruppenbacher et al., 1993; Wolska 
and Solaro, 1996). Our group conducted cell isolations at 37ᵒC both to reduce cell-exposure 
to non-physiological parameters, and for relevance to available literature (Bers, Lederer and 
Berlin, 1990; Zhou et al., 2000). 
As discussed previously, the extent of digestion of the heart is assessed through colour and 
feel of the tissue as well as time elapsed, which are arguably qualitative assessments 
requiring a certain degree of experience, and thus prone to experimental error. Immortal 
cardiac cell lines such as HL-1 have been created, however newly dissociated cells from 
fresh hearts are accepted to be more physiologically relevant to the myocardium than cells 
which have been in culture for prolonged periods (Gizak et al., 2009). 
3.2 Cell isolation shortcomings 
Cardiomyocytes used in this work were consequently obtained through the most successful 
method to date, namely retrograde coronary perfusion of collagenase enzyme solution, 
followed by tissue dicing and agitation. This technique is thought to be superior to the 
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“chunk” method, where tissue is diced and agitated in enzymatic solution without perfusing 
through existing vasculature (Louch, Sheehan and Wolska, 2011). Despite undergoing 
substantial improvements over the past few decades, the available techniques were until now 
unable to measure the variability of cell quality following isolation due to low throughput. 
This being the case, patch clamping techniques have now been refined to allow high-content 
experiments to be carried out on individual cells. Allowing high-fidelity recordings of the 
membrane potential in excitable cells, the study of cardiomyocytes has largely benefitted 
from this. 
In healthy tissue, electrical coupling of neighbouring cells via gap junctions reduces the 
variability of electrical behaviour observed, contrasting with a highly pronounced variability 
in AP durations from isolated cells from the same tissue, as demonstrated in this thesis. 
Quantifying this heterogeneity requires populations of cells to be sampled from individual 
animals, which the manual patch-clamping techniques currently do not permit. Automated 
patch clamping devices have become more widely available in the past 5 years, albeit at 
prohibitive costs, and limited to a single recording per cell, as it is a terminal procedure, 
mechanically breaching the cell membrane.  
The following experiments used optical techniques to study isolated CM electrophysiology 
at higher throughput than had ever been done previously. To achieve this, the new voltage-
sensitive dye FluoVolt was used to measure real-time membrane potential. Its properties 
were compared with the well-established voltage indicator di-4-ANEPPS. Protocols were 
optimised to use FluoVolt at concentrations yielding maximal signal-to-noise without 
causing obvious cell damage. Optics were specifically selected to further reduce photo-
induced damage and increase SNR. Finally, a custom-designed stimulator/incubator bath 
system was developed to best accommodate the new working distance of the new objective 
while maintaining stable temperatures, and further improve throughput. 
3.3 Section Aim 
The work outlined in this chapter aimed to improve on current approaches for studying 
isolated CM electrophysiology, namely developing a medium/high-throughput technique to 
sample large cell populations (n=100-500 cells) from individual hearts by optimising optical 
dyes and optics, and combining the apparatus with an automated microscope stage to 
precisely record individual cell locations for multiple measurements. This contrasts with 
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current methods (e.g. patch-clamping, low-throughput optical methods) which are currently 
limited by small sample sizes, and single recordings per cell (i.e. 5-10 cells per day). 
3.4 Hypothesis 
Optimising several separate aspects of a fluorescent-based voltage measurement technique 
will lead to substantial increases in sample size per heart. 
3.4.1 Incubator/stimulator 
In collaboration with the Bioelectronics department at Glasgow University (Nosrat Mirzai 
and Jakub Czyzewski), we co-designed an aluminium-body stage incubator (see Figure 3.1) 
built to accommodate two glass-bottomed dishes (MatTek, 35 mm). Accurate temperature 
modulation (±0.1ᵒC) was achieved using two Peltier units and 50 mm cooling fans. A 
thermistor was installed inside the incubator and a thermostat-loop controlled temperature 
within 1ᵒC. The lid of the device was also machined out of aluminium for adaptable heat-
modulation. Two graphite electrodes (2cm x 5cm x 2mm) were inserted through the lid and 
secured using either Teflon or plastic (3D-printed PLA) inserts and immersed in the cellular 
medium. A pacing stimulator (MyoPacer, Ionoptix) was used to generate 2 ms, 40 volt pulses 
at the desired frequency (1 – 3Hz). 
 
Figure 3.1 Diagram of stage stimulator/incubator bath. Two Peltier elements accurately 
regulate plate temperature and 50 mm fans radiate excess heat. Graphite electrodes are 
used to generate field stimulation inside the dish medium. 
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3.5 Results 
3.5.1 Temperature calibration and modulation 
Action potential duration (APD) is strongly influenced by slight changes in temperature. The 
temperature of the incubating plate was consequently thoroughly calibrated to achieve a 
stable temperature in the dish (37ᵒC). The custom-built temperature incubator was 
incrementally heated and calibrated for dish temperature using three separate methods. The 
plate itself was fitted with a temperature probe, accurate within ±0.1ᵒC. A temperature 
sensitive sticker was placed in the dish (±1ᵒC; LabTemp 40), in 2 mL Krebs solution. Finally, 
a temperature probe (±0.1ᵒC; Oko-labs) was submerged in the medium. The temperature 
setting of the plate was set as a thermostat with upper and lower limits of 1ᵒC. The starting 
temperature was set at 37ᵒC (upper limit= 38ᵒC; lower limit = 36ᵒC), and the dish was 
equilibrated for 10 min prior to each recording, incrementally to 46ᵒC. The final plate 
thermostat was set to 42ᵒC to achieve 37ᵒC in the dish (Figure 3.2). 
 
Figure 3.2 Temperature regulation of dish incubator. Calibration of plate temperature with 
recorded cellular medium temperature using temperature probe. XY plot shows plate 
temperature setting (thermistor) against actual recorded temperature inside dish using 
Oko-Labs probe. Incremental temperature measurements were taken from 37ᵒC to 46ᵒC 
thermistor temperature. In red is the acceptable temperature range for experimentation, 
and in green the upper and lower thermostat limits imposed on the temperature controller. 
Testing the thermoregulating plate showed the temperature of the Peltier elements required 
was strongly linearly correlated with the dish temperature, however due to thermal losses, a 
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+5ᵒC offset was required to achieve 37ᵒC in the dish. Temperature regulation was 
thermostatically regulated within 1 degree Celsius (e.g. For 37ᵒC, plate temperature was set 
to Low = 41ᵒC; High = 42ᵒC).  
As the temperature-sensitive stickers agreed with the Oko-Labs probe, they were used as a 
convenient method to ensure successful temperature equilibration prior to each experiment. 
3.5.2 Temperature dependence of action potential duration 
To test temperature modulation and repeated voltage measurements in isolated cells, a group 
of FluoVolt-loaded isolated cardiomyocytes were serially paced at 2 Hz at five incremental 
temperatures. Cells were equilibrated for 10 min at each temperature step prior to recording 
(see Figure 3.3 below). 
 
Figure 3.3 Demonstration of APD temperature dependence. X-axis shows incubating plate 
temperature (mean ± SD shown). 
A group of seven cells were paced at 2Hz at 5 incremental temperatures, ranging from 28ᵒC 
to 38ᵒC (Figure 3.3). Action potentials were recorded at each time-point to demonstrate the 
critical importance of accurately controlling the temperature of the dish during the 
experiment. This simple demonstration illustrates the importance of accurate temperature 
modulation in this type of experiment. Furthermore, this shows the reliability of this method 
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by performing repeated fluorescent measurements of the same cell 5 times over a 60 min 
period without causing cell death or APD prolongation. 
3.5.3 Temperature equilibration period 
 
Figure 3.4 Temperature equilibration effect on APD. Example of temperature equilibration 
effect on APD measurements over time (Temperature plate set at 37ᵒC). A single-phase 
exponential decay regression was fitted to sequential cell recordings illustrate the initial 
temperature equilibration in the dish in the first 10 min. 
Figure 3.4 outlines the importance of temperature equilibration prior to making 
measurements of APD90 in isolated cardiomyocytes. The experimental protocol was 
subsequently standardized to begin with a minimum of 10 min incubation, and 5 min 
electrical stimulation prior to recording (see Figure 5.3). 
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3.5.4 Experiment duration and APD drift 
 
Figure 3.5 APD stability over variable experimental time.  A. Action potential duration 
plotted against recording order in 75 separate incubations (ncells = 3776) of variable 
duration (15min – 180min). A linear regression was fitted to the APD in each dataset. 
There is no evidence of APD drift as a function of time spent incubating. The segmented 
x-axis (>100) shows the few cases where over 100 recordings were made in a single dish, 
with an emphasis on the vast majority of experiments (≤50), where ~50 recordings were 
made before changing cell batch. B. The APD90 of the two groups was compared and no 
difference was found (P>0.05; paired t-test). C. Heterogeneity was assessed by 
comparing the coefficient of variation of the 1st to the 25th recording and the 26th to the 
50th, respectively. No difference between groups was found (mean ± SEM shown, paired 
t-test). 
Cell viability and AP consistency over the duration of experimental time was assessed using 
all single-cell optical recordings acquired throughout this thesis, whereby each cell dish 
yielded cell APD recordings (from ~30 to >100) made in series over time . The AP duration 
was plotted in order of recording (each cell typically took ~20s – 60s to locate and record) 
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and no drift or change in variability was observed across hundreds of cells in several hearts 
(see Figure 3.5, panel A). In each experiment, a linear regression was fitted to each APD90 
population of recordings from individual cells which were chronologically recorded. In 
~70% (50/71) cases, the slope was not significant from zero (i.e. no APD drift over time). In 
the remaining 30% of cases where it was significantly different from zero, 47% (10/21) had 
a positive slope and 53% (11/21) had a negative slope. As it was suspected that time post 
isolation would affect cellular health and potentially APD, and consequently during 
experiments involving regional comparisons, a maximum of 30 min (~50 recordings) per 
dish was used to minimise potential cell deterioration during incubation. Furthermore, in 
experiments comparing several conditions (e.g. endocardial vs. epicardial cells) the order 
was randomized for each experimental repeat, ensuring time was not a function of any 
differences found between groups. As cellular heterogeneity was also later assessed, the 
variability of APD over time was assessed by comparing the mean APD90 and coefficient of 
variation of the early recordings versus the later recordings within a same incubation (see 
3.5.4, panel B and C, respectively). There was no significant change in APD or heterogeneity 
as a result of incubation duration. 
 
 
Figure 3.6 Progressive stages of cell deterioration. Intact cell (left) with clearly identifiable 
cell edge and parallel sarcomeres. (center) Cell edge is beginning to show signs of 
membrane blebbing (arrow). (right) Hypercontracted cell. These balled-up myocytes 
would often still display signs of electrical activity and must consequently be entirely 
excluded from the field of measurement. 
After cells are enzymatically isolated, they begin to gradually deteriorate over several hours 
(see Figure 3.6, center). A large proportion of the total number of cells isolated die from 
membrane damage, and consequently a common criticism of isolated cell studies is that the 
surviving population of cells may not be representative of the total population present within 
cardiac muscle. The selection of surviving cells in the dish was made based on the most 
dependable characteristics indicating CM health in vitro. Namely, these are rod-shape, clear 
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striations, sharp cell edges, quiescence in normal Ca2+ conditions, and synchronous response 
to electrical stimuli (Louch, Sheehan and Wolska, 2011). 
3.5.5 Dye excitation and AP prolongation 
Illumination of dye-loaded cells necessary for dye excitation induces photodamage through 
formation of reactive-oxygen-species (ROS) and free radicals (Schaffer et al., 1994). While 
antioxidants have been used to reduce the oxidative photo-damage associated with 
fluorescent probes, a far more efficient method to overcome this problem is to reduce dye 
concentration and improve light collection. Optimising dye concentration was therefore 
critical to prevent damage induced APD prolongation (see Figure 3.7). Manufacturer-
recommended 1:1000 FluoVolt concentration proved far too high, and caused action 
potential prolongation and cell quiescence or hyperpolarisation within seconds of 
illumination. Using FluoVolt at 1:6000 did not prolong the action potential, following up to 
a full minute of continuous illumination, while retaining a superior SNR than di-4-ANEPPS. 
 
Figure 3.7 APD prolongation with FluoVolt. Example AP train of two cells (top & bottom, 
respectively) separately loaded with 6 µM di-4-ANEPPS or 1:1000 FluoVolt. (*) FluoVolt 
show superior SNR, however over only 10s there is evidence of AP prolongation. (**) The 
AP continues to prolong, exceeds 1000ms (CL) after less than 20s, and consequently fails 
to repolarise before the pacing stimulus. From 20s to 30s, action potentials prolong 
beyond several seconds, eventually leaving the cell in a permanently hyperpolarised, 
inexcitable state. 
Figure 3.7 shows two cells subjected to three immediately sequential, 10-second 
illuminations using 470 nm LED light. All traces were filtered identically (10-point 
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averaging). Di-4-ANEPPS displays poor signal-to-noise compared to FluoVolt, and APD 
does not appear prolonged following 30 seconds total illumination.  
3.5.6 SNR testing: di-4-ANEPPS vs. FluoVolt  
 
Figure 3.8 Comparison of Di-4-ANEPPS and FluoVolt signal-to-noise. (a) Signal-to-noise 
ratio (amplitude/noise) expressed as a relative comparison to di-4-ANEPPS (6µM) and 
several dilutions of FluoVolt. FluoVolt was superior at every tested concentration with 
respect to SNR. (b) Example action potential trace showing amplitude and noise (standard 
deviation of noise).  
Discerning signal from noise is easier when using fluorophores with high ∆F/F per mV. The 
more efficient the fluorophore, the smaller amount of illumination required to produce an 
analysable signal. Comparing the new voltage-sensitive dye FluoVolt to an established dye 
(di-4-ANEPPS) determined FluoVolt was over 4 times brighter at the recommended 
concentration (1:1500) than di-4-ANEPPS (6 µM) (see Figure 3.8). Due to the known AP 
prolonging effects demonstrated previously, 1:6000 concentration was chosen as it did not 
cause AP prolongation with increased illumination time 
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3.5.7 Positive staircase testing 
Adult cardiomyocytes exhibit a positive gain in fractional shortening with increased pacing 
frequency. This is called the positive staircase effect, or Bowditch effect in the whole heart. 
It is also known as the Treppe effect (Treppe is German for stairway). Generally following 
increased sympathetic stimulation, diastole decreases in duration, which overwhelms the 
Na+/K+ ATP-ase in its ability to extrude the Na+ brought in by the sodium-calcium exchanger 
(NCX). One of the mechanisms through which the staircase effect occurs is through a build-
up of calcium within the cell. NCX brings 3 Na+ ions down their concentration gradient 
(inwards) in exchange for one Ca2+ ion to flow out. In this case, unusually high 
concentrations of Na+ inside the cell decreases the efficiency of NCX, increasing 
intracellular Ca2+ concentration, where it can trigger CICR and activate myofilaments more 
readily, thus increasing inotropy. In isolated myocytes undergoing no external forces from 
neighbours as they would in tissue, this translates to increases in fractional shortening with 
increasing pacing frequency. This effect has been observed at the organ level, at the tissue 
level in papillary muscle and trabeculae, as well as in single cells. (Gibbons and Fozzard, 
1975; Wang et al., 1988; Shiels, Vornanen and Farrell, 2002). 
To assess the impact of FluoVolt on cell physiology, the staircase effect was used as a gauge 
of cellular health. Cells loaded with fluorescent dyes were subjected to a triple-frequency 
pacing protocol, during which both voltage and contractility metrics were recorded (see 
Figure 3.9). 
 
Figure 3.9 Positive staircase effect in isolated rabbit CM. Example traces of fractional 
shortening in a field-stimulated cardiomyocyte at 3 incremental frequencies. The 
amplitude of contraction increases from 1 Hz to 2 Hz, and does not significantly increase 
in all cells from 2 Hz to 3 Hz (See Figure 3.10) 
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Figure 3.10 Effects of voltage-sensitive dye-loading on staircase effect. (a) Control cells 
(dye-free) show an average increase in shortening amplitude with an increase in pacing 
frequency from 1Hz to 2Hz, but not 2Hz to 3Hz. (b) Cells loaded with 6 µM di-4-ANEPPS 
also display a positive inotropic effect (P<0.01). (c) Cells loaded with 1:1500 FluoVolt do 
not increase their fractional shortening with increased frequency (P>0.05). (d) Cells 
loaded with 1:6000 FluoVolt display a clear positive staircase, effectively identical to 
controls. Fractional shortening is expressed as extent of shortening at each beat. (e.g. 
15% fract. short. means the cell is 85% as long during systole as it is at rest.) 
The staircase effect in rabbit (LV) isolated cardiomyocytes. Fractional shortening increases 
in cells paced sequentially at 1 Hz, 2 Hz, and 3 Hz. Fractional shortening significantly 
increases from 12.8 % to 18.4 % (1 Hz to 2 Hz) (P<0.001). There was no significant change 
in shortening from 2 Hz to 3 Hz.  
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Cells loaded with 6 µM di-4-ANEPPS also displayed a positive staircase, similarly to 
controls. Cell shortening increased from 9.4 % to 12.8 % (1 Hz to 2 Hz) (P=0.002). No 
change in fractional shortening was observed between 2 Hz and 3 Hz. 
Cells loaded with 1:1500 FluoVolt did not exhibit a staircase effect, indicating cellular 
damage and disruption of physiology. There was no change in fractional shortening at any 
frequency (P>0.05). Interestingly, some of the cells displayed decreased contraction 
amplitudes with increased stimulation frequency (2Hz to 3Hz). 
Cells loaded with 1:6000 FluoVolt displayed a preserved staircase effect, with a significant 
shortening increase from 12.7% to 16.9% (1 Hz to 2 Hz) (P<0.001). Once again there was 
no significant difference between 2 Hz and 3 Hz. 
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3.5.8 Removal of motion artefact using blebbistatin 
Using fluorescent probes to record membrane potential relies on collection of light at a 
specific wavelength from the field of view. However, the transient changes in fluorescence 
observed may not always be a factor of the observed variable (e.g. Vm, Ca
2+). This is 
particularly important for optically mapping the heart using single wavelength dyes, as 
motion artefact is one of the most prominent issues encountered in accurately measuring 
fluorescence changes on the surface. Fluorescent tissue moves in and out of the field of view 
as the heart contracts and relaxes, causing fluctuations in fluorescence which are independent 
of voltage changes in the tissue. To remedy this, E-C uncouplers have been extensively used 
in whole heart experiments to inhibit the contractile proteins responsible for contraction, 
without significantly affecting electrical activity in the tissue. 
The mechanical uncoupler blebbistatin was chosen for these sets of experiments. It inhibits 
myosin II ATPase and prevents actin-myosin motility, thereby inhibiting contraction 
(Kovács et al., 2004). Having been used in rabbit and rat, (Farman et al., 2008; Fedorov et 
al., 2007). it has also been demonstrated, unlike other uncouplers such as BDM to have 
minimal effects on ECG parameters and atrial or ventricular electrophysiology. While it was 
deemed innocuous enough at the concentrations and for the purposes of this work, it is worth 
noting recent research shows potential APD prolongating properties of blebbistatin in whole 
heart experiments (Brack et al, 2013). These findings used 5 µM Blebbistatin for 60 min in 
whole hearts, while single cell work in this thesis used 3 µM for 20 min. 
Motion artefact in the form of a positive deflection in phase 2 and 3 was identified in almost 
all cells loaded with FluoVolt (1:6000). Incubation with 3 µM blebbistatin reduced the 
amplitude of the artefact but did not completely eliminate it (see Figure 3.11).  
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Figure 3.11 Motion artefact reduction with blebbistatin. Example trace of fluorescent AP 
recorded in the same cell before and after blebbistatin incubation. The “bump” artefact 
observed in the baseline recording (black) is reduced with blebbistatin, but still prominent. 
Furthermore, the was evidence of moderate APD prolongation in cells treated with 
blebbistatin, however motion artefact prevented reliable quantification of this. 
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Figure 3.12 Exaggerated motion artefact with improper iris placement. Effect of rectangular 
iris placement on single wavelength fluorescent recordings in the same cell. (a) Incorrect 
iris placement. Part of the beating cell is coming in and out of the FOV, which creates 
fluctuation in fluorescence associated with the surface of the cell exposed to the light -
sensing equipment (PMT) rather than a change in membrane voltage. (b) Correct iris 
placement. The whole cell is visible during contraction, entirely removing the artefact. 
It is worth noting the contraction and motion themselves are not a factor in artefact creation, 
if the illumination power is constant across the sampling area. Unlike whole-heart imaging, 
where illumination across a field of several cm will almost inevitably be non-homogeneous, 
fluorescent recordings in single cells across a few hundred µm is unaffected by this, and was 
consequently not an issue in this thesis. The proper shutter placement, indicated in Figure 
3.12(b) was used throughout this thesis. 
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3.6 Discussion 
3.6.1 Post-isolation cell viability 
Ion current run-down is a known phenomenon in patch clamping, whereby the calcium 
current of the patched cell decreases over time, caused by a rise in intracellular calcium and 
a loss of high-energy compounds such as ATP (Belles et al., 1988). The rate of decay varies 
depending on the technique; in whole cell patch, the seal can be maintained for short periods, 
but if the seal fails or tears through the cell membrane, the cell cytosol comes in direct contact 
with the outside, and the cell dies. With on-cell patching (intact membrane), single cell 
experiments can last substantially longer. Using fluorescent techniques, the experimental 
throughput gradually increased with each iteration of the recording protocol, and experiment 
duration followed suit. Experiments initially lasted approximately ~1 hour, yielding ~5-20 
cells. After optimising our protocol, provided the cell isolation yielded a reasonably high 
live:dead cell ratio, experiments then lasted for to 4-8 hours after isolation. While this was a 
positive development, cells still eventually deteriorated over time after enzymatic isolation. 
Counter-intuitively, keeping cells incubating at 37ᵒC and 5% CO2 prior to experiment 
dramatically reduced the survival rate. Cells kept in Ca2+-free Krebs solution at room 
temperature survived longest and did not show signs of deterioration in terms of membrane 
blebbing and inexcitability (see Figure 3.6). Batches of cells were therefore kept at ~0 mM 
Ca2+ until immediately prior to recording. 
The potential risk of using cells to record physiological parameters several hours after being 
removed from the heart was investigated by plotting the AP duration as a function of time, 
using recordings from a sample of 18 experiments, acquired over a span of 24 months. There 
was no evidence of APD drift, up to 8 hours post-isolation.  
3.6.2 Plate design and temperature regulation 
Unlike commercially available stage incubator systems, our system enabled access to a 
higher aperture objective, previously hindered by its narrow working distance (WD=0.18 
mm), by machining a wide enough opening on the bottom of the plate, and adjusting the 
plate temperature to account for the resulting heat loss. 
While light collection efficiency could have been further improved, by further increasing 
aperture >1.0 by using a water or an oil-immersed lens, this would have likely caused a 
localized heatsink effect, requiring more complex, less efficient methods for regulating 
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temperature such as objective heat-sleeve or microscope enclosure. Furthermore, this would 
have added another variable to the system, requiring optical calibration with temperature 
changes. 
Signal-to-noise ratio of FluoVolt 
Manufacturer recommended concentrations for FluoVolt were determined unsuitable for 
isolated CM study. At recommended concentrations, FluoVolt caused cell damage and was 
found to negatively affect the staircase effect in isolated CMs. Reducing the concentration 
used to ~1/6th resulted in a higher signal-to-noise ratio than previously used dyes, and did 
not affect cell survival, AP duration, or contraction kinetics. Furthermore, using FluoVolt 
caused a net reduction in potential photo-damage, by permitting a reduction in excitation 
light power due to its increased brightness, combined with increased light collection 
efficiency. 
3.6.3 Motion artefact reduction 
Using FluoVolt for measurement of membrane potential caused an artefact in the early to 
late plateau phases of the action potential (phase 2 and 3), originally thought to be caused by 
movement of the cell within the FOV. this artefact was found to be caused by a portion of 
the cell membrane moving in and out of the FOV. Through systematic placement, this 
artefact was removed entirely, and did not require the use of a myosin inhibitor, by 
standardising the placement of a rectangular iris in the optical path (Figure 2.2) such that the 
whole recorded cell was visible during its entire contraction cycle (see Figure 3.12). 
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4 Chapter 4: Signal processing and 
deconvolution 
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4.1 Background 
4.1.1 Fluorophores 
Using fluorescent molecules to study biological mechanisms harnesses the process of raising 
the energy state of a molecule using light of wavelength λ1 and recording the emitted light 
of a wavelength λ2 originating from the fluorophore as it returns to its original energy state, 
where λ1 < λ2 The energy of the emitted photons (λ2) from the fluorophore must be less than 
that of the excitation light used (λ1), as some energy is inevitably absorbed by the fluorophore 
itself to undergo conformational change. This is known as the Stokes shift (Ronzhina and 
Cmiel, 2012). Exposing the sample to light of a specific wavelength can be achieved through 
various methods including a xenon/mercury arc lamp, halogen lamp, light emitting diodes 
(LED), or lasers (Efimov, Nikolski and Salama, 2004; Fast, 2005). It is worth noting this 
process is not perfect, as many factors affect the efficiency of light re-emission by a 
fluorophore. Each fluorophore has a specific quantum efficiency (Φ), defined as a ratio of 
emitted light divided by absorbed light. The wavelengths used for excitation will affect the 
quantum efficiency, for example lower energy (red) light can penetrate deeper into tissue 
without being absorbed, forming the basis for 2-photon microscopy. Resonant energy 
transfer also affects the emission efficiency, by either causing an adjacent molecule to emit 
light (FRET), or absorb it. Fluorophore bleaching is particularly problematic and often 
requires post processing, such as the fitting and subtraction of a linear or exponential decay 
curve to the recorded fluorescent trace, to correct for it. 
4.2 Section Aims 
Explore the limitations of the optimised optical system (Chapter 3) and develop a protocol 
for deconvolving wavelength emissions from spectrally overlapping fluorescent dyes. 
4.2.1 Limitations of fluorescent measurements 
Fluorescent measurements, like other indirect measurements of biological events, have 
limitations. The most basic of these is the correlative factor of fluorescent change to change 
in the variable of interest. If fluorescence emitted by a fluorophore is a function of something 
other than the variable - e.g. pH, temperature, background fluorescence - the accuracy and 
relevance of the measurement decreases, and must be accounted for. This creates a strong 
incentive to choose fluorophores reasonably specific to a singular variable. Secondly, 
fluorophore resistance to bleaching must be optimised or else accounted for, for the duration 
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of the measurement. Thirdly, the type of fluorophore used, either single (non-ratiometric) or 
dual wavelength (ratiometric), should be selected where appropriate, because single-
wavelength dyes emit light as a function not only of the concentration of fluorophore present 
in the sample, but also of the light intensity used for excitation, and length of the optical 
pathway (Fukano, Shimozono and Miyawaki, 2008). Ratiometric dyes (Fura-2, Indo-1) 
overcome this problem by shifting either excitation or emission spectra as a function of 
substrate availability. Light sampled from two different wavelength bands allows the ratio 
of these signals to determine the absolute concentration of substrate in the sample at a given 
time. Lastly, a common issue arising when using multiple fluorophores in the same sample 
is light contamination and generation of mixed wavelength light from two or more 
fluorescent molecules, either native to the sample (notably background fluorescence) or 
artificially inserted via other fluorophores. 
4.2.2 Noise and sampling rate 
Detecting sufficient amounts of fluorescence in response to small changes in substrate 
without interfering with physiology is paramount to quantifying substrate changes 
accurately. Dye response must also be reasonably fast to resolve events in the millisecond 
range. To measure voltage changes in isolated cells in our experiments, the new voltage-
sensitive dye FluoVolt was used. FluoVolt is a single wavelength dye, reportedly displaying 
25% fluorescence increase per 100mV increase, with a sub-millisecond response time 
(Thermo Fisher). 
Fast dye response combined with high sampling rate constitutes increased temporal 
resolution. We measured voltage at a rate of 10 kHz, or one measurement every tenth of a 
millisecond. Although the theoretical ceiling of our temporal resolution was therefore 0.1 
ms, trace filtering reduced this, as discussed later. 
Calcium measurements made using Fura-4F were sampled at 500 Hz. This 20-fold reduction 
in sampling rate does not affect the reliability of calcium measurements as the fastest events 
we recorded ranged in the 10-20 ms range. 
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4.2.3 Upstroke temporal resolution 
Fast events such as the upstroke of the action potential are difficult to resolve temporally. 
The sampling rate of 10 kHz provided 0.1 ms resolution as discussed previously, however 
due to the noise present in any fluorescent traces, adjacent filtering was applied to recordings 
for analysis. A standard 3-point boxcar filter applied 15 times was consistently applied, 
meaning the fastest fluorescent change observable using these settings was 1.5 ms (Figure 
4.1). The advantage of 15 passes of a 3-point average over a single pass 15-point average 
was better fit of the inflection points of the upstroke. 
 
Figure 4.1 Signal noise and upstroke resolution. Example of an action potential upstroke. 
An unfiltered trace (left) and a filtered trace (15-pass 3-point averaging, right). The signal 
noise impairs the accuracy of baseline and peak detection. Consequently, this filtering 
level was used for consistency in results, chosen as an optimal point between fast 
sampling and accurate baseline and peak detection. 
Filtering smoothes the trace and reduces the noise at baseline and peak of the upstroke, but 
also causes the slope to slant forward, and thus become artificially prolonged. Conversely, 
minimal or no filtering of the trace conserves high temporal resolution but makes the 
detection of the baseline and maximum peak of the upstroke equally difficult to assess. A 
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“sweet spot” filtering was selected for consistency with typical experimental SNR, without 
negatively impacting measurements. 
Detecting and quantifying events in the millisecond range requires high signal-to-noise and 
sampling rates. The upstroke of action potentials in typical cells is in the order of 0.5-1.5 ms 
(Berecki et al., 2010). Our theoretical maximal resolution was 0.1 ms, allowing at best 5 to 
30 points to be recorded during an average upstroke. While this is theoretically possible, 
smoothing was applied to accurately determine the start and end of the upstroke, and the 
impact on other measurements such as repolarisation duration (APD90) was assessed (Figure 
4.4). 
4.2.4 Signal deconvolution 
The excitation spectrum of Fura-4F and FluoVolt overlap in the 380 nm range (See 
Methods). Exciting Fura-4F using 380 nm wavelength light consequently also excited 
FluoVolt, albeit less efficiently than the dedicated 470 nm wavelength. The resulting calcium 
transient recordings consequently consisted of a combination of both emissions, which 
required spectral deconvolution to extract one from the other. To achieve this, the relative 
effect of each excitation light used was plotted against the corresponding FluoVolt response 
(Figure 4.7). In turn, this allowed a corrective factor to be applied to the traces to remove the 
stray voltage signal from the calcium signal, as shown below. 
𝐶𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑 𝐹𝑢𝑟𝑎 4𝐹 𝑟𝑎𝑡𝑖𝑜 =  
340𝑛𝑚 𝑠𝑖𝑔𝑛𝑎𝑙 − (470𝑛𝑚 𝑠𝑖𝑔𝑛𝑎𝑙 ×  𝑐𝑜𝑟𝑟 𝑓𝑎𝑐𝑡𝑜𝑟 − 𝑐𝑜𝑛𝑠𝑡𝑎𝑛𝑡)
380𝑛𝑚 𝑠𝑖𝑔𝑛𝑎𝑙 − (470𝑛𝑚 𝑠𝑖𝑔𝑛𝑎𝑙 ×  𝑐𝑜𝑟𝑟 𝑓𝑎𝑐𝑡𝑜𝑟 − 𝑐𝑜𝑛𝑠𝑡𝑎𝑛𝑡)
 
The “correction factor” and “constant“ above respectively describe the slope and y-intercept of the 
linear relationship between FluoVolt signal at different excitation wavelengths determined in Figure 
4.7. 
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4.3 Methods 
4.3.1 Fluorescent noise and upstroke measurement error 
A group of cells from the same animal was loaded with FluoVolt as previously described in 
Chapter 2. The resulting action potential traces recorded were analysed twice, using adjacent 
averaging, or no filtering at all. The resulting upstroke times were plotted to assess the impact 
of filtering on the measurement reliability of fast events. 
Additionally, square wave traces simulating action potentials trains with <100 µs upstrokes 
were generated artificially. A range of Gaussian noise typically encountered experimentally 
(σ = 300 - 1000) was added to the traces and they were analysed identically to experimentally 
generated APs. The traces were analysed once without any trace processing and once with 
our optimised adjacent averaging. 
4.3.2 Fluorescent noise and APD measurement error 
Identically to 1.2.1, the APD90 values recorded from the same group of cells were analysed 
with and without filtering, and the resulting APD values were compared graphically. 
4.3.3 Quantifying FluoVolt vs. Fura-4F cross-excitation 
Isolated CMs were loaded with FluoVolt as described previously, and incubated at 37ᵒC. 
The cells were not electrically paced, and consequently only the baseline fluorescence was 
recorded for each cell. Individual cells (n=25) were exposed to 470 nm light for 2.5s, 
simulating a voltage recording, and immediately thereafter exposed to the 340nm/380nm 
alternating wavelength excitation, simulating a calcium recording. The fluorescence 
detected after each excitation protocol in the same cell permitted the direct comparison of 
the fluorophore response (signal intensity) of FluoVolt to 470 nm, 340 nm, and 380 nm 
excitation, respectively. A linear regression was plotted to quantify this effect and to 
calculate a correction factor for trace deconvolution. 
To successfully deconvolve the stray FluoVolt fluorescence from the Fura-4F emission in 
real time, a triple-excitation protocol was implemented (Figure 4.2).  
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4.3.4 Fluorophore triple excitation protocol 
Excitation of FluoVolt and Fura-4F nearly simultaneously requires rapid, successive turning 
on and off of the excitation LEDs. Similarly to the ratiometric method used with Fura-4F, 
an extra step was added to the excitation protocol. 
 
Figure 4.2 Triple excitation protocol. (A) Diagram of new excitation protocol for near-
simultaneous excitation of FluoVolt and Fura-4F. First the 470nm LED is switched on for 1 
ms, followed by the 340nm LED for 1 ms, and finally the 380nm LED for 1 ms. This is 
repeated for the entire duration of the recording, and consequently allows a sampling rate 
of 333.3 Hz for voltage and calcium. The recording examples (B) are offset by 1 ms from 
one another. 
4.3.5 Semi-automated signal deconvolution using Python 3 
The fluorescent transients generated from the triple wavelength excitation protocol were 
saved to three .csv files for subsequent deconvolution using Python program (written by 
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Quentin Lachaud) using the Spyder integrated development environment (IDE). The files 
were sequentially opened, and the correction factor was applied where appropriate to each 
trace. Corrected ratio (340 nm/380 nm) traces were saved to a separate folder and converted 
to .mda (native CellOPTIQ) format, which could then be imported into the CellOPTIQ 
platform, identically to all other recorded traces (See Appendix). 
4.3.6 Impact of fluorescent noise on CellOPTIQ measurement 
accuracy 
Measuring action potential characteristics such as repolarisation duration and upstroke time 
consistently between cells and experiments relies on a standardised method of trace analysis. 
This analysis was integrated within CellOPTIQ and specific parameters such as noise 
filtering must be constant across experiments to ensure comparability between datasets. Due 
to the variable nature of fluorescent signal noise recorded from dye-loaded cells, the 
precision with which key voltage characteristics were measured also varied. This was 
quantified by using a modelled train of action potentials from the Dempster model 
(Dempster, 2016), onto which gaussian noise representative of experimental conditions was 
added (Figure 4.5). Artificial trains of five action potentials at 3 frequencies were generated 
and analysed using standard CellOPTIQ protocol and compared to the modelled noiseless 
trace. 
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4.4 Results 
4.4.1 TRise and trace filtering 
 
Figure 4.3 Effect of systematic filtering on upstroke resolution. Example of artificial AP 
trains (N = 10, respectively) with very fast upstroke speed (TRise < 0.1 ms) analysed with 
a range of gaussian noise artificially applied to the trace. Filtering the trace (Boxcar 
filtering, 15 pts) artificially prolonged TRise by 1 ms irrespective of initial noise level. 
Unfiltered traces show increased TRise measurement at noise of 750 S.D. and above. 
Typical experimental noise S.D. ranges from 300 to 1000 (arbitrary units). 
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Figure 4.4 Impact of trace filtering on upstroke and repolarisation. Example AP upstroke 
with smoothing applied (A) and without (B) Pink dots denote % depolarisation from total 
upstroke amplitude (10-100%). A best fit spline was applied to each trace to determine 
percentage depolarisation. TRise was calculated as Upstroke90% – Upstroke10%. Scatter 
plots of TRise and APD90 values derived from the same group of cells. TRise is heavily 
affected by filtering (see Figure 4.3), while APD90 is not. (dotted line for reference; x = y) 
Figure 4.4 above shows that applying standard filtering to traces impacts the measurement 
of action potential upstroke but not APD90. The lack of correlation before and after filtering 
seen in TRise underlines the difficulty of measuring such a fast event. With minimal or no 
filtering, the signal noise makes it challenging to detect the beginning and end of 
depolarisation. With excessive filtering, the beginning and end of depolarisation are 
straightforward to detect, but the trace becomes artificially slanted due to adjacent averaging. 
A 15-pass, 3-point filter was determined optimal and applied throughout. 
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4.4.2 Measuring AP duration with variable noise 
 
Figure 4.5 Example of simulated artificial fluorescent trace. (left) Simulated action potential 
(Dempster, 2016) with no added noise and (right) with added gaussian noise using the 
mean σ encountered experimentally (n = 10). 
 
 
Figure 4.6 Testing CellOPTIQ accuracy. Bar chart comparison of measured AP durations (σ 
= 300) with theoretical values (dotted lines). Mean and S.D. were plotted but error bars 
were too small to display (expected values for APD90 represent the known duration of 
artificial APs, before applying signal noise). 
Figure 4.6 shows measuring APD90 in dye-loaded cells proved highly reliable 
experimentally, as was not affected significantly by trace filtering. Furthermore, APD90 
Artificial trace 
Noise distribution 
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measurement was very accurate and consistent at a set noise level in artificial action 
potentials (Figure 4.6). Unlike TRise, typical APD90 values can range from 80-800 ms, and 
therefore are not significantly affected by trace filtering. Nonetheless, standard boxcar (15-
pass 3-point) filtering was applied to all traces to standardise analysis. 
4.4.3 Trace deconvolution corrective factor calculation 
In order to remove stray FluoVolt fluorescence from calcium traces recorded in cells loaded 
with both Fura-4F and FluoVolt, the relative excitation of FluoVolt using 340nm and 380nm 
wavelengths was compared to the 470nm LED (used to excite FluoVolt). The percentage 
excitation achieved relative to the 470nm LED was recorded (see Figure 4.7) and applied in 
the deconvolution process (see 4.2.4).  
 
Figure 4.7 Relative excitation of FluoVolt using Fura-4F excitation wavelengths. Linear 
regression of FluoVolt excitation using 340nm (purple) and 380nm (blue) LEDs plotted 
against 470nm excitation (x = y; dotted line). 340nm and 380nm light excites FluoVolt with 
9% and 41% efficiency, respectively. 
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Figure 4.8 Example of Fura-4F signal deconvolution. Example 340nm/380nm ratio trace 
prior to, and after deconvolution. The negative deflection prior to upstroke (*) and sharp 
inflection (**), an artefact from AP repolarisation, are diminished after removing the scaled 
FluoVolt fluorescence from each channel. Note the change in Y-axis scale used. 
Figure 4.8 shows the subtle effect of deconvolution on the calcium transient kinetics, 
removing the negative deflection (*) caused by the action potential upstroke and the 
abnormally sharp inflection in the decay phase (**). More strikingly, the baseline and 
amplitude (diastolic and systolic calcium) were increased after deconvolution. This effect 
was quantified in Figure 4.9. 
The Ca2+ baseline and peak were both affected by light-contamination (i.e. signal originating 
from FluoVolt caused by 340/380nm excitation), and subtraction of this stray signal allowed 
for quantification of absolute concentrations of Ca2+ in the cell. For example, 340nm 
excitation of Fura-4F displays a decrease in fluorescence at the 510nm wavelength when 
[Ca2+] increases inside the cell. This coincides temporally with an increase in fluorescence 
from FluoVolt, during the action potential upstroke, creating a compound fluorescence 
signal.  
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4.4.4 Effect of deconvolution on calcium metrics 
 
Figure 4.9 Effect of deconvolution on calcium parameters. Comparison of baseline (left) 
and amplitude (right) of calcium transients before deconvolution and after deconvolution. 
Both baseline and amplitude are significantly different from control cells (loaded with Fura-
4F alone) before deconvolution (P<0.01 and P<0.05, respectively. Paired t-test). The 
corrected baselines and amplitudes do not show significant difference from control (Fura-
4F-only) cells (P>0.05). All cells originated from a single heart (N = 1). 
Without the deconvolution step, using the 340nm/380nm excitation protocol would result in 
both Fura-4F and FluoVolt being excited and emitting in the same wavelength-range. This 
means the recorded fluorescence would be both a measure of the intracellular calcium within 
the cell, as well as the membrane potential. After deconvolving the traces, fluorescence 
analysis allows ratiometric measurements to be made: in other words, it achieves a measure 
of absolute calcium concentration, free of contamination from other known fluorescent 
sources. Before deconvolution, both baseline fluorescence (diastolic Ca2+) and peak 
fluorescence (systolic Ca2+) are significantly different in dual loaded cells from controls 
loaded with Fura-4F only (P>0.01 and P>0.05, respectively.). After deconvolution, baseline 
and peak fluorescence values are no longer statistically different from controls (P>0.05). 
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4.5 Discussion 
4.5.1 Action potential upstroke resolution 
Measuring the upstroke duration of action potentials using fluorescent signals presents the 
logistical challenge of finding the optimal signal-to-noise (i.e. Maximizing SNR while 
avoiding toxic dye concentrations) combined with high signal-sampling rates. Comparing 
TRise measurements in “perfect”/noise-free, action-potential-like waveforms demonstrates 
the limitations of the methodology in quantifying the duration of events in this range. Using 
patch clamping to measure Vm directly benefits from high sampling rates (~50kHz) as well 
as very low noise. While indirectly measuring Vm using fluorescence substantially increases 
experimental throughput, the technique suffers from considerably higher noise. This noise 
varies from cell to cell and between experiments, as cell size and membrane health may 
affect how much dye is present in each cell. Assuming membrane turnover is standard from 
cell-to-cell, variability in cell loading is unlikely to affect experimental SNR. Figure 4.3 
shows that a boxcar averaging (15 pass; 3 points) was optimal to measure TRise consistently, 
irrespective of noise levels. While the measure of upstroke time is improved following 
filtering, the absolute duration (0.1-1.5 ms) has been irreversibly and artificially prolonged. 
Consequently, measures of upstroke time using this method are more relevant to paired 
experiments comparing a baseline with a transient effect (i.e. drug), rather than reported as 
absolute values, given the limited resolution of the measurements. 
4.5.2 Action potential repolarisation measurement accuracy 
In contrast to fast events like AP upstrokes, repolarisation occurs over hundreds of 
milliseconds and is not nearly as sensitive to trace filtering as TRise. The systematic filtering 
applied to traces (boxcar 15) did not affect any measure of repolarisation kinetics such as 
APD90. Repolarisation kinetics measurement using CellOPTIQ was found to be highly 
reliable (see Figure 4.6), and not affected by the typical noise encountered experimentally. 
4.5.3 Signal deconvolution 
By quantifying the relative fluorescent crosstalk of FluoVolt using excitation LEDs meant 
for Fura-4F excitation, the relative contamination of both 340nm and 380nm channels was 
used to subtract the stray voltage signal from calcium recordings made using a triple 
sampling protocol. The effectiveness of this method was tested on a batch of cells from a 
single heart and was found to restore the ability of the technique to make ratiometric 
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measurements in these cells, despite the presence of FluoVolt. A shortcoming of this method 
was the reduction in sampling rate caused by the triple excitation protocol. As mentioned 
previously, calcium kinetics in whole cell measurements occur in the 10-400 ms range, 
which does not necessitate sampling in the kHz range to resolve. Alternatively, rapid voltage 
kinetics such as TRise will be affected by the low sampling rate tested (333Hz). A solution to 
this is to record action potentials at 10 kHz, followed by an accurate ratiometric measurement 
of calcium at 333Hz. This approach used on cells beating at 2 Hz would mean each cell 
could yield both a measure of voltage and calcium within 5s, maintaining the throughput of 
the technique, as well as repeated paired measurements in individual cells, as necessitated in 
drug studies. 
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5 Chapter 5: Electrophysiology of MI cell 
populations 
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5.1 Background 
5.1.1 Regional electrophysiological differences 
Cardiomyocytes originating from different regions of the healthy myocardium can have 
dramatically different action potential shapes and repolarisation profiles. Ion channel protein 
expression, membrane trafficking, and pore-opening kinetics underlie the differing 
electrophysiological properties of cells in distinct cardiac regions. 
Different electrophysiological properties have been identified across the ventricular wall in 
vitro. Notably through the description of canine M-cells in the 1990s, a subtype of mid-
myocardial cells with long AP durations as well as disproportionate AP prolongation at slow 
heart rates (Pye and Cobbe, 1996; Antzelevitch, 2007), and in response to APD-prolonging 
agents (Prenner et al., 2016). They have now been found in many species, including guinea 
pig, rabbit, pig, and humans (Taggart et al., 2001). 
Sub-endocardial and sub-epicardial cells also display marked electrophysiological 
differences. Most notably, Phase 1 of the action potential differs between endocardium and 
epicardium. Sub-epicardial cells have a characteristic phase 1, indicative of a pronounced 
transient outward K+ current (Ito), weaker in sub-endocardial cells (Figure 5.1). They also 
have different AP durations, as the endocardium is typically reported to repolarise slower 
than the epicardium, indicating a subtly different interplay of repolarising channel 
expressions and opening kinetics. 
 
Figure 5.1 Illustrative example of transmural canine action potentials differences. Example 
of canine epicardial and endocardial action potentials at 300ms and 2000ms cycle 
lengths, respectively. (Taken from Litovsky & Antzelevitch 1989).The search for transmural 
repolarisation gradients is not new. Taggart et al., (2001) investigated repolarisation 
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patterns in the normoxic and hypoxic human heart, and did not find evidence of 
repolarisation gradients across the ventricular wall at physiological (<200bpm) or 
bradycardic heart rates (~40bpm). They propose that the presence of cell coupling and 
electrotonic current flow could mask repolarisation differences between individual cells 
and regions. The absence of gradients from their experiments could also be explained in 
part by the degree of pathology present in these experiments. It is possible that ischemia-
induced, pro-arrhythmic electrophysiological states (i.e. transmural gradients) only develop 
acutely and immediately preceding arrhythmic events, prior to which their presence could 
be masked by cell-cell coupling and to an extent, buffered by the repolarisation reserve in 
whole hearts. Conversely, other groups have reported transmural repolarisation gradients in 
ventricular wedge preparations and in vivo, although at non-physiological, long cycle 
lengths (Antzelevitch et al., 1999). 
The different AP characteristics encountered throughout the heart actively contribute to 
normal E-C coupling in health, and are subject to disruptive stimuli in pathology. Cellular 
death resulting from ischaemic damage (MI) to the heart muscle can slow or prevent signal 
propagation across cardiac tissue, increasing the probability of re-entry and disrupting 
cardiac rhythm. Depending on the size of the infarct zone, long-term effects of cellular death 
can result in tissue remodelling, subtly altering repolarisation uniformity between layers and 
regions of the ventricle.  
5.1.2 Cellular pathophysiology of MI-induced heart failure 
Heart failure (HF) is broadly defined as a complex syndrome of physiological responses to 
the heart’s inability to maintain an output sufficient to meet the needs of the organism. The 
effect of HF on cardiac function has been extensively studied over the past decades. A 
description of the pathophysiology of HF is beyond the scope of this thesis, so only select 
aspects of remodelling relevant to this work will be discussed. 
Heart failure as a result of remodelling following MI is a major cause of sudden cardiac 
death (SCD), but the electrophysiological mechanisms underlying it are not clear. In general 
terms, remodelling-induced HF causes cell hypertrophy, AP prolongation, decreased Ca2+ 
handling, resulting in weaker muscle contraction and depressed cardiac output (Pogwizd et 
al., 2001). The physical adaptions of the failing heart are manifold, and their manifestation 
highly variable from individual to individual. As this thesis aims to demonstrate, not only 
 
 
87 
 
baseline states can vary between animals but also the remodelling following injury which 
was explain the broadness of HF-associated effects. 
After injury caused by acute or chronic ischaemia, structural and functional changes start to 
occur. Cellular hypertrophy is one of the key markers of HF, where individual CMs increase 
in length and width (McIntosh, Cobbe and Smith, 2000), with reports of ~60% lengthening 
in dilated cardiomyopathy (Beltrami et al., 1995). Hypertrophy is also evident at the organ 
level, with increases in heart size by 20-30%. Left ventricular hypertrophy on its own can 
occur through cardiovascular training in athletes, but in the case of pathophysiologically 
compensated hypertrophy, this adaptation initially aids in maintaining cardiac output 
following decreased function in the ventricle through cellular loss and impaired Ca2+ 
handling. In severe cases, hypertrophy alone is no longer sufficient, and cardiac output 
continues to decrease as the heart further dilates. This is referred to as decompensated 
ventricular hypertrophy, which can further progress to HF. 
The physiological mechanisms supporting these adaptations are also complex and multi-
faceted. Chronic remodelling following ischemia has been shown to affect Ca2+ handling as 
well as gene and protein expression. For example, a reduction in the number of L-Type Ca2+ 
channels has been reported, with little to no change in ICa-L (current), indicating an 
upregulation of individual channel function (Glukhov et al., 2010). The importance of 
remodelling in the predisposition to arrhythmia has been outlined in several animals models 
(Akar and Rosenbaum, 2003; Glukhov et al., 2010). 
In this work we investigated the cellular electrophysiological adaptations, using a rabbit 
model, 8 weeks after ligating a major supply vessel of the LV apex. The degree and severity 
of remodelling present in the animals used in these experiments is not claimed to represent 
HF, but it does provide a consistent and comparable stage of compensated LV dysfunction 
in the mammal heart. 
5.1.3 Rabbit model of MI 
Several models of disease are current in the study of cardiac pathology. Our study utilised 
the ligation of the left descending coronary artery (LDA) of the rabbit. The vessel is 
permanently ligated, and the heart is harvested 8 weeks after ligation. This model provides 
consistent apical LV infarct formation and early stages of cardiac remodelling, comparable 
to what is often encountered in human post MI, such as a decreased ejection fraction (see 
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Figure 5.12), cellular hypertrophy, APD prolongation, and comparable scar formation on the 
ventricle wall. 
5.1.4 Frequency-dependent AP duration and MI model 
As heart rate increases, the R-R interval, representing the time between ventricular 
depolarisations on the ECG trace, becomes proportionately shorter. At the cellular level, 
faster rates decrease the duration of the action potential across the heart, however this effect 
is not homogeneous (Litovsky and Antzelevitch, 1989). Due to inherent differences in 
channel expressions across the cellular subtypes, the AP response to changes in rate across 
different regions like endocardium and epicardium varies. Data suggests that different 
expression levels of the transient outward potassium current (Ito) between endocardium and 
epicardium result different degrees of APD shortening following increases in rate (e.g. 0.5 
Hz to >3 Hz). 
APD prolongation is one of the hallmarks of reported electrophysiological features of heart 
failure at the cellular level (Wickenden et al., 1998), expressed as prolongation of the QT 
interval on the ECG trace (Shah et al 2019). The degree of APD prolongation is not uniform 
across CM subtypes. McIntosh et al. (2000) found that rabbit sub-endocardial cells exhibited 
markedly longer AP durations than sub-epicardial cells in their controls (sham) animals. 
Following induced HF, sub-epicardial and mid-myocardial cell AP durations increased, 
while sub-endocardial cell AP duration decreased. These changes result in the reduction of 
the endocardium-epicardium APD difference, and reduce left-ventricular heterogeneity 
(McIntosh, Cobbe and Smith, 2000). 
5.1.5 Section Aims 
This transmural gradient in AP duration and shape will be investigated at the individual cell 
level to quantify the heterogeneity of the electrical phenotypes responsible for this average 
difference between regions, in control and MI hearts.  
The data in the literature from which electrophysiological differences were derived comes 
from many different animals, but from a relatively small number of cells from each animal. 
Although the average APD differences are reported, the extent of variation across myocyte 
populations is not known. The hypothesis of this work is that the myocyte 
electrophysiological phenotype spread contributes to “normal” electrophysiology in healthy 
hearts, and its alteration could consequently represent a possible explanation for the highly 
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variable nature of the pro-arrhythmic substrate found in vivo. Pharmacological intervention 
to reverse or inhibit the loss of an electrophysiological phenotype spread could therefore find 
relevance in the treatment of arrhythmias of the failing and remodelled heart. 
The focus of this chapter is to (1) characterise the AP duration of isolated cells populations 
from the rabbit LV at three different rates, and how these AP durations vary (i) within 
individual hearts and (ii) between animals (see intra- and inter-animal variation in Figure 
5.2). These data were used as a physiological baseline against which cells originating from 
infarcted hearts (MI model) were compared. (2) To compare intrinsic differences in 
electrophysiological properties between the inner (sub-endocardial) and outer (sub-
epicardial) layers of the left ventricle in control (Sham) and infarcted (MI) tissue. 
 
Figure 5.2 Diagrammatic example of hierarchical levels of variation studied A. Compound 
variation of all cells from every heart sampled. B. Variation between mean APD from each 
heart. C. Mean variation within each individual heart (requires large cell populations). 
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5.2 Methods 
5.2.1 MI APD response to change in rate 
Left-ventricular (LV) cardiomyocytes were isolated from infarcted (MI) and sham-operation 
(sham) animals and loaded with the voltage-sensitive dye FluoVolt as previously described. 
The dish was placed in the incubator/stimulator and temperature equilibrated for 10min 
before initiating pacing equilibration for 5min (2ms pulse, 3 Hz) using a stimulus amplitude 
of 40V (exceeding depolarisation threshold). 
Action potentials from each cell were sequentially recorded at 3Hz, 2Hz and 1Hz, 
respectively. Approximately 15 beats were allowed after each frequency change for APD to 
reach steady state (in line with measurement of restitution in whole hearts). This was 
repeated throughout, and the dish was replaced with fresh cells every 30 min. The 
experiment was terminated when cells began to show signs of deterioration (i.e. unable to 
follow 3Hz pacing, membrane blebbing, ectopic beats, hypercontraction). 
 
Figure 5.3 Pacing and recording protocol diagram. Multi-frequency recording protocol. 
Each cell was serially paced at 3Hz, 2Hz and 1Hz. A minimum train of 5 APs was 
recorded for each frequency. 
5.2.2 Transmural comparison of sham and MI hearts 
The sub-epicardial and sub-endocardial layers of the left ventricle were dissected (~1 mm 
thickness) apart and cells were isolated enzymatically and loaded with FluoVolt as 
previously described. Cells were paced at 500ms cycle length (2 Hz) using field stimulation. 
This frequency was selected because it was the rate at which ~95% cells would consistently 
pace, and consequently the most relevant comparison to rabbit physiology attainable through 
field stimulation. 
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In infarcted hearts, the infarct (apical) and peri-infarct regions were removed. The same 
procedure was applied to an approximation of this region location and size in sham hearts. 
5.3 Results 
5.3.1 Multi-frequency APD response in MI vs sham 
 
Figure 5.4 Frequency dependence of APD. Relationship between APD90 and pacing 
frequency in sham and MI cell populations. Data shown as mean ± SD. (n1000ms=233 vs. 
170; n500ms=225 vs. 174; n333ms=225 vs. 98, Nhearts = 6 vs 3-6*. 
As shown in Figure 5.4, the positive relationship between APD and cycle length was evident 
in both sham and MI groups. No difference between MI and sham was found at 3 Hz (208±10 
vs 206±15 ms, respectively; P>0.05, unpaired t-test), however MI APD was significantly 
longer than sham at 1 Hz (370±13 vs 328±15ms, P<0.001, unpaired t-test) and 2 Hz (277±13 
vs 245±15 ms, P<0.001, unpaired t-test). This conventional display of cell populations, using 
mean ± SD, masks variation present within cell groups, illustrated in Figure 5.5, made using 
the same datasets.  
*Cell groups were sampled from 6 MI animals, 3 of which were not stimulated at 3Hz.  
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Figure 5.5 Histogram of cell populations serially paced at 3 frequencies. Frequency 
distributions of paired measurements in individual cells at 3 Hz (green), 2 Hz (red) and 1 
Hz (blue). Sham and MI animals are compared. Gaussian curves were fit to each 
population of cells at every frequency tested. Three separate measures of statistical 
variation were used to describe population spread between groups: standard deviation, 
coefficient of variation, and interquartile range. All three show an increase in variation at 
all frequencies in MI. All measures of variation measured showed MI APD values were 
more heterogeneous than in sham. 
Displaying these data as mean and standard error can be misleading, as contrasted in Figure 
5.5, where each APD90 measurement population is shown to largely overlap at all three 
frequencies, despite heterogeneity decreasing with increases in pacing rate, as described by 
an increase in kurtosis and a decrease in measures of spread (STD, CoV, IQR). While mean 
APD90 did not differ significantly between groups at 3 Hz, MI cell populations were more 
variable than sham populations at all rates in three measures of variability, including 
coefficient of variation (σ/mean), inter-quartile range (75th - 25th% percentile), and standard 
deviation (σ).  
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5.3.1.1 Sham vs MI distribution analysis of APD90 measurements 
 
Figure 5.6 Degree of normality comparisons. P-value result of normality testing (D’Agostino 
& Pearson normality test) on populations of APD90 measurements from MI and sham 
hearts at 3 pacing rates. P-values below 0.05 (dotted line) were significantly different from 
Gaussian (Unpaired t-test). The majority of APD90 measurements were normally 
distributed. Line and error bars show mean and SEM. 
Conventional normality testing on data populations has a binary outcome. This may not be 
an ideal way to appreciate the degree or extent of distribution normality. Consequently, each 
cell population from individual animals were subjected to a normality test and its p-value 
was recorded. If the p-value of the test was greater than 0.05, the distribution was not 
considered consistent with a Gaussian distribution, and conversely, if the p-value was less 
than 0.05, the distribution was considered inconsistent with a Gaussian distribution. 
The P-values from the normality test of each cell population were plotted and compared 
between conditions at each frequency tested. No significant differences were found between 
groups except at 2 Hz (P<0.05, t-test). This result shows that pacing frequency did not affect 
APD90 distribution shape significantly, and that MI animals displayed a greater degree of 
normality at 2 Hz than sham animals (see Figure 5.6), however this is unlikely to carry 
biological significance. 
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5.3.1.2 APD, triangulation and upstroke in sham and MI 
As discussed previously (Figure 2.11), the triangulation index was calculated as the time (in 
milliseconds) between APD30 and APD90, and scaled for total AP duration (APD90).  
 
Figure 5.7 Action potential morphology parameters in response to changes in pacing 
frequency. Relationship between pacing frequency and AP characteristics between sham 
and MI groups. Data plotted are mean ± SEM. Statistical comparisons between MI and 
sham at same frequency. (n1000ms=233 vs. 170; n500ms=225 vs. 174; n333ms=225 vs. 98, 
Nhearts = 6 vs 6) 
5.3.1.3 Sham vs MI AP characteristics at 3 frequencies 
APD90 and APD30 were both prolonged in MI at slower pacing frequencies (1 Hz and 2 Hz) 
(P<0.001) but not at 3 Hz (P=0.461). Triangulation index of action potentials was not 
significantly different between sham and MI except at 2 Hz (P<0.01, unpaired t-test). TRise 
was not significantly different between groups at any frequency tested (see Figure 5.7). 
A prolongation in APD90 and APD30 in the MI group reflects a loss of hERG in these animals, 
prolonging the plateau phase of the AP, and delaying repolarisation compared with controls. 
Triangulation does not appear to vary between groups at 2 of the 3 frequencies tested, 
indicating the overall shape factor of the action potential remains relatively constant in early 
stages of HF, compared with controls. 
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5.3.1.4 Heterogeneity in AP characteristics 
The coefficient of variation (CoV) was used to provide a measure of heterogeneity of 
datasets. Firstly, CoV was calculated for each animal and plotted as the mean ± SEM to 
describe typical heterogeneity within animals (Figure 5.8). Secondly the CoV of all cells 
(from all animals) was calculated to describe heterogeneity between animals. The latter was 
plotted with mean CoV only as each condition is treated as N = 1 (Figure 5.9). 
 
Figure 5.8 Intra-animal variation comparisons. Intra-animal variation. Mean (±SEM) of 
individual animal coefficients of variation to compare animal-animal across pacing rates. 
APD30 and APD90 heterogeneity significantly increases at slower pacing rates. No 
significant difference was found between sham and MI groups at any frequency. 
Significance levels displayed on figure describe sham comparisons only (One-way 
ANOVA, Tukey’s multiple comparison test). Frequency groups were not different from one 
another in MI (Mixed-effects analysis) (n1000ms=233 vs. 170; n500ms=225 vs. 174; n333ms=225 
vs. 98, Nhearts = 6 vs 3-6). 
Figure 5.8 above shows no difference in MI heterogeneity across tested frequencies. One-
way ANOVA could not be used due to 3 animals missing the 3Hz group (not tested 
experimentally). 
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Figure 5.9 Inter-animal variation comparisons. Coefficient of variation of APD30, APD90, 
TRise and Triangulation index. The coefficient compares all cells from animals as a single 
population, hence the absence of error bars. Variation decreases as a function of faster 
pacing frequencies in both groups. MI repolarisation (APD30, APD90, Triangulation) is more 
variable than sham at all frequencies tested. Upstroke time does not change noticeably 
between groups or frequencies.(n1000ms=233 vs. 170; n500ms=225 vs. 174; n333ms=225 vs. 
98, Nhearts = 6 vs 3-6). 
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5.3.2 Transmural AP morphology in infarcted heart 
 
Figure 5.10 Transmural voltage parameter comparisons between sham and MI. Box plots of 
AP parameters comparing sub-endocardial and sub-epicardial cells in sham and MI 
animals at 2 Hz pacing frequency. Data points shown are each animal mean. Nsham=7, 
NMI=9) 
Hierarchical analysis (Code available in Appendix, p139) was carried out to compare 
transmural differences in four action potential parameters in sham, and MI animals (Table 
1). The early repolarisation duration (APD30) was not significantly different between regions 
in either sham or MI. Sham animals displayed a significant transmural difference in APD90, 
which was lost in MI animals. Triangulation index normalised to AP duration was not 
different transmurally in either condition. Finally, AP upstroke duration was not found to be 
different between any of the tested groups of animals. 
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5.3.3 Transmural analysis of AP morphology in cell populations 
Below is an illustrative example of standard statistical analyses (unpaired t-tests) in pooled 
groups of cell populations from 7 (sham) and 9 (MI) animals. 
 
Figure 5.11 Mean endocardium-epicardium APD90 difference in sham and infarcted hearts. 
Mean transmural difference in repolarisation time between sub-endocardium and sub-
epicardium of individual animals (each point = EndoAPD – EpiAPD). The sham group was 
significantly different from 0 (One-sample t-test; P = 0.026), while MI was not (One-sample 
t-test; P = 0.536). Sham and MI ΔAPD90 were not significantly different from one another 
(P>0.05). 
Figure 5.11 illustrates the importance of hierarchical approaches to clustered datasets. 
Standard t-test analysis using the mean difference between endocardial and epicardial APD90 
only provides a limited appreciation of population behaviour, and does not take into account 
the number of cells sampled to calculate each heart’s mean APD90.  
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Figure 5.12 Ejection fraction (%) and APD90 Mean ejection fraction (%) (±SEM) plotted 
against the mean APD90 of endocardium and epicardium in MI and Sham groups. 
Endocardium-epicardium gradient is lost in the MI group. (Nendo= 6; Nepi= 6). 
A factor influencing remodelling, and changes in APD gradients across the LV wall is the 
degree of severity of the infarct. One way of quantifying the extent of LV damage is to assess 
each animal’s ejection fraction (EF%). While this is only an indication of the damage 
sustained by the muscle, it provides context to the range of transmural APD found in the MI 
group. The ejection fraction was assessed by echocardiography. Analysis of the 
echocardiographic data from both groups was blinded. 
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Table 2 Region-specific (sub-endocardium) comparison of sham and MI AP parameters. 
Comparison of sub-endocardial cell AP parameter means in pooled populations of sub-
endocardial cells from sham and MI animals (unpaired t-test). 
 
Table 3 Region-specific (sub-epicardium and sub-endocardium) comparison of sham and MI 
AP parameters. Comparison of sub-epicardial cell AP parameter means in pooled 
populations of sub-epicardial cells from sham and MI animals (unpaired t-test). 
Statistical comparison between sham and MI sub-endocardial cells found prolongation of 
APD30, APD90 and TRise in MI (+8.1 ms; + 4.3 ms; +0.8 ms, respectively). Triangulation 
index was unchanged in either region. Sub-epicardial MI cells also exhibited prolonged 
APD30, APD90 and Trise relative to shams (+8.4 ms; + 27.3 ms; +0.6 ms, respectively. The 
largest change observed in the MI group was APD90 prolongation, prominent in the sub-
epicardium region, and modest in the sub-endocardium region (+27 ms and +16 ms, 
respectively). 
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5.3.4 Transmural action potential heterogeneity 
 
Figure 5.13 Inter- and intra-animal variation comparisons. (a) Box plots of individual animal 
coefficients of variation during upstroke (TRise) and phases of repolarisation (APD90, 
APD30, Triangulation index). (b) CoV of all cells sampled from sham and MI hearts (N = 7-
9). 
The CoV of AP parameters was not significantly different between regions 
(endocardium/epicardium) or conditions (sham/MI), except for AP triangulation, which was 
significantly greater in sham endocardium than MI endocardium (One-way ANOVA, P = 
0.025). (see Figure 5.13) 
Comparing cell populations from all animals showed consistently higher CoV in MI groups 
in TRise, APD30 and APD90, but not triangulation. 
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Figure 5.14 Diagram of MI-induced AP changes. Diagrammatic representation of the action 
potential differences found transmurally between the sham and MI groups.  
(1) Both MI endocardium and epicardium have significantly slower upstroke rates than sham 
in respective regions. (2) APD30 increases in both regions, and remains significantly different 
between endocardium and epicardium in MI. Both endocardium and epicardium show 
increases in APD90, and do not differ significantly after MI, predominantly due to epicardial 
APD90 increase (see Figure 5.14). 
5.3.4.1 Hierarchical analyses 
Hierarchical analyses of endocardium-epicardium repolarisation differences within 
individual animals showed the transmural repolarisation gradient present in sham was lost 
in MI (Table 1). 
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5.3.5 Transmural APD90 in MI and sham 
 
Figure 5.15 Histograms of APD90 in sub-endocardium and sub-epicardial cells from sham 
and MI animals. Subplots show gaussian fit of all endocardial/epicardial cells from all 
animals together. Tables show mean APD90 in each group and measures of variation. 
Transmural comparison of APD90 between sham and MI animals shows a high degree of 
APD90 overlap between cells from the inner and outer layers of the left ventricle. While the 
shift in distribution is detected statistically using these large datasets, a given cell picked at 
random would give no indication as to its origin within the LV from its APD alone, once 
again highlighting the importance of obtaining adequate numbers of observations via 
increased throughput in studies of this nature. 
Sham animals show significantly greater APD in endocardium 259±14 ms vs epicardium 
246±15 ms. On average, MI animals show no difference between groups (Hierarchical test, 
P = 0.0109 and P = 0.516, respectively.). 
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5.4 Discussion 
5.4.1 Electrophysiology of the left ventricle 
5.4.1.1 Action potential upstroke 
The speed of action potential upstroke was measured in all cells, and shows no significant 
change between pacing frequencies ranging from 1 to 3 Hz. Furthermore, no difference in 
upstroke time was found between cells in populations sampled from the whole ventricle of 
sham and MI animals. While these measurements may well reflect the underlying physiology 
(i.e. INa function), it is likely that measuring fast events in the millisecond range using 
fluorescent techniques does come with limitations and systematic error (e.g. trace filtering). 
Such limitations and potential improvements were addressed in Chapter 4. The estimates of 
TRise derived from these action potential trains may therefore only be relevant in the context 
of relative comparison between groups measured and analysed using identical filtering. 
5.4.1.2 Action potential duration 
The APD90 measured in MI cell populations from 6 animals confirms earlier work 
(McIntosh, Cobbe and Smith, 2000), showing no difference in APD between MI and control 
at fast, pseudo-physiological rates (3 Hz), and an APD difference of +20-30 ms only evident 
at slower pacing rates (1 Hz and 2 Hz). This work constitutes a significant improvement in 
cell sampling throughput per animal, using 12 animals (6 sham, 6 MI) versus 39 animals (14 
sham, 25 MI) to sample ~200-300 cells. Moreover, increasing the sample size (cells per 
animal) provided a measure of variability between cells as well as animals in response to 
different pacing frequencies. 
Additionally, the frequency and transmural site-dependence of prolongation was 
demonstrated previously in a model of LV hypertrophy (McIntosh et al., 1998), which was 
successfully replicated here. 
5.4.1.3 Action potential morphology 
Action potential shape was assessed by reducing it to a single number, triangulation index. 
It constitutes a useful tool to quantify the degree of plateau present on a given AP. It is 
important to note the triangulation index reported in literature so far has been the duration 
between APD30 and APD90, in milliseconds. This work differs from this convention, by 
considering the total duration of the AP (Chapter 2) and reporting triangulation as a ratio. 
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Changes in AP triangulation previously reported may consequently have been positively 
skewed by comparing AP groups of different durations, potentially overestimating increased 
triangulation in this way. This normalisation of AP triangulation to AP duration was 
especially important in this work as the AP durations were increased in MI, spuriously 
increasing the non-normalized triangulation index. 
While AP triangulation was found to be higher in the MI group at only one of the tested 
pacing frequencies (2 Hz), its heterogeneity among populations showed an increase in MI 
hearts, at all three frequencies tested. 
5.4.1.4 Inter- and intra- animal heterogeneity 
The coefficient of variation (σ/ɥ) was selected as a measure of heterogeneity due to its lower 
sensitivity to outliers than standard deviation or range, as it is weighted for the mean. CoV 
was recorded for each animal to determine the degree of cell-cell variation present within 
individual animals. CoV was also calculated for all animals using all values obtained from 
individual cells, thus conserving total variation within populations. The main factor affecting 
heterogeneity in these experiments was a slowing in pacing rate. As the pacing rate 
approached normal rabbit physiological rates, heterogeneity decreased equivalently between 
MI and sham cell populations, and no significant difference was found between groups at 3 
Hz. 
LV heterogeneity increased at slower pacing rates, but was interestingly not found to differ 
between MI and sham groups. The APD heterogeneity of isolated cell populations is greater 
than in the whole heart (~2 to 5-fold at equivalent pacing rates, see Appendix, Table 5), 
principally due to an absence of cellular coupling through gap junctions, as well as intrinsic 
variation in ion channel expression between individual cells. 
Inter-animal heterogeneity was greater in MI than sham in APD90, APD30, and triangulation, 
but not upstroke time. This was true of all pacing frequencies, and most pronounced at the 
slowest rate (1 Hz). This is relevant to the reported phenomenon of disparate drug effects 
observed between males and females, different ethnic groups, and genetically predisposed 
groups such as LQTS patients (Niemeijer et al., 2015). Given the heterogeneity found in 
inbred, gender, weight and age-matched rabbits, it is not unreasonable to think other factors 
such as gender, ethnic group, or pathophysiological profiles would also drive comparable or 
superior levels of heterogeneity in affected groups. 
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5.4.2 Transmural comparisons 
5.4.2.1 Action potential upstroke 
The AP upstroke was not found to differ between sub-endocardial and sub-epicardial cells 
from the same heart. The upstroke was significantly prolonged in sub-endocardium and sub-
epicardium MI (~50%) compared to sham. This slowing in depolarisation time from resting 
membrane potential has previously been reported in border zone cells (Pinto & Boyden, 
1999) and following acute and chronic ischaemia (Rodríguez, Trayanova and Noble, 2006). 
It is worth noting that the measurement of upstroke could serve as a quality control of cells 
sampled, by demonstrating the absence of M-cells. M-cells have faster rates of 
depolarisation (
𝑑𝑉
𝑑𝑡
max) and distinctly longer APs than other cell subtypes (Antzelevitch et 
al., 1999; McIntosh, Cobbe and Smith, 2000), and their absence from our cell populations 
can attest none, or few mid-myocardial cells were present. 
Transmural heterogeneity of TRise was much greater than other AP parameters, (CoV 60-
70%), approximately two-fold that of the repolarisation indexes. This phenomenon is likely 
the result of a strong sensitivity of TRise to small changes in sodium channel expression and 
activation. The maximal rate of depolarisation (
𝑑𝑉
𝑑𝑡
max) of CMs is highly sensitive to the 
number of active Na+ channels participating in membrane depolarisation. The resting 
membrane potential affects the activation state of these channels, potentially prematurely 
causing some to open if the cell is already slightly depolarised but still below threshold (~-
85mV). Furthermore, dV/dtmax is inversely proportional to the square of the sodium ion 
current activation, which explains substantial changes in upstroke time can be caused by 
small fluctuations in INa activation. 
Na+ channels have been reported to decrease in number and delocalise from the cell ends 
following MI, and for the cell resting potential to increase after infarct-induced remodelling. 
This work showed TRise in MI animals was found to be slower, and display greater 
heterogeneity than sham, which further supports the concept of subtle changes in sodium 
channel activity causing asynchrony in cell depolarisation. 
5.4.2.2 Action potential duration 
Two types of comparisons were made with regards to transmural action potential assessment. 
Firstly, endocardium-epicardium differences were compared, using a hierarchical approach 
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to adequately account for the clustering present within individual hearts. Secondly, region-
specific comparisons were made between MI and sham groups. The early index of 
repolarisation APD30 was not found to differ between sub-endocardium and sub-epicardium 
in either sham or MI groups. Later stages of repolarisation (APD90), in contrast, showed a 
loss of difference in the MI group, retained in sham. 
The consequences of the transmural gradient of APD is unknown. Myles et al., (2010) 
showed APD was directly dependent on activation sequence, by stimulating endocardially 
and epicardially, showing a reversal in APD gradient. The natural conclusion of this work is 
that cellular differences in APD are a consequence, and not a cause of the endo-epi position, 
and may result from the chronic electrical and mechanical differences across the ventricular 
wall in both health and disease. The loss of transmural difference therefore may reflect 
different mechanical conditions in the LV wall post MI. 
Cell with very short action potentials (<100ms) were rare but did cause an increase in 
measures of repolarisation heterogeneity, specifically in the MI procedure group (see Figure 
5.15). Large reductions in APD have been attributed to the KATP channel in isolated cells, 
whereby activation of KATP leads to AP shortening and decreased cell excitability (Faivre 
and Findlay, 1990). The opening of a very small fraction of KATP channels present in CMs 
(1%) has been shown to cause a 50% decrease in APD (Faivre and Findlay, 1990), and as 
little as 10% opening causing cell inexcitability altogether (Findlay et al., 1989).  
5.4.2.3 Action potential morphology 
The index of triangulation was not found to differ transmurally between sub-endocardium 
and sub-epicardium in sham or MI. 
5.4.2.4 Hierarchical analyses 
Hierarchical analysis confirms a loss in repolarisation gradient between sub-endocardium 
and sub-epicardium regions of the MI rabbit model. This technique highlights the potential 
pitfalls of conventional clustered statistics in multi-condition groups with varying sample 
sizes. 
 
 
109 
 
5.4.3 Conclusions 
The study of pathology requires a proper appreciation of the variability of electrophysiology 
in normal states. The electrical behaviour of isolated CMs exhibits vastly more variability 
than coupled tissue, where these cellular differences and potential sub-populations of 
behaviours could go unnoticed. As discussed later, marrying single cell experiments to 
whole heart studies could help further understand the implication of cell-cell heterogeneity 
on the overall electrical behaviour of the heart. 
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6 Chapter 6: Regional heterogeneity in left 
ventricle 
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6.1 Background 
6.1.1 Heterogeneous electrical activity of the left ventricle 
As discussed previously, electrical phenotypes can vary considerably between different 
regions of the heart muscle. It has been proposed that electrical gradients above a certain 
threshold across the myocardium contribute to pro-arrhythmic activity (Maruyama et al., 
2011). The exact physiological prerequisites for the generation of these gradients is not 
currently well-understood. While a measure of repolarisation heterogeneity is expected, too 
much, or too little, variation could serve as a pro-arrhythmic substrate. Quantification of 
repolarisation heterogeneity has so far been sampled the at organ level using 2D mapping of 
the epicardium, as other methods using single cells, such as patch clamping, are not able to 
sample enough cells to provide meaningful measures of spread. 
As would be expected, AP duration in electrically coupled tissue is quite tightly constrained, 
where any given myocardial area is very well synchronized with its neighbouring tissue, 
forming the near-homogeneous signal triggering synchronous muscle contraction. The 
heterogeneity in repolarisation duration of individual cells in isolation is considerably 
higher. This variation, masked in intact tissue, could reveal previously unknown underlying 
differences between two hearts with seemingly identical ECG waveforms.  
Quantification of heterogeneity between cell populations sampled from discrete regions of 
the myocardium could therefore provide valuable information about the underlying electrical 
phenotypes within the ventricle. In this way, two hearts could host very different arrhythmic 
risk, despite displaying potentially identical electrical phenotypes determined by ECG or 
optical mapping. Furthermore, cardiac remodelling following a myocardial infarction is 
known to affect repolarisation duration. The effect of remodelling on cell heterogeneity has 
not yet been investigated, and could play a key role in arrhythmogenic processes. 
Naturally occurring repolarisation variation in specific regions of the myocardium has also 
not been quantified due to logistical issues encountered with throughput. The primary 
hypothesis of this study is that the repolarisation heterogeneity present within a single heart 
by far outweighs any variation encountered between hearts.  
Lastly, by sub-sectioning heart regions for individual study we will identify whether the 
heterogeneity in the whole ventricle stems from (1) homogeneous variation in all regions or 
(2) islands of high and low variation distributed spatially across the LV wall. 
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6.1.1.1 Regional specificity of APD of endocardium and epicardium 
The characteristics of the action potential across the LV (endocardium-epicardium) was 
investigated in Chapter 4. While the data agreed with literature with regards to average APD, 
we found extensive variability across both regions studied. This section will summarise the 
average electrical behaviour and the degree of heterogeneity present in several sub-divisions 
of the rabbit LV.  
6.1.2 Region-specific IKr inhibition  
As discussed earlier, the hERG channel, generating IKr, is the dominant channel responsible 
for the final stage of repolarisation (phase 3), supplemented by IKs. Inhibition of IKr in results 
in increased APD and effective refractory period (ERP). Commonly used drugs targeting 
IKr include dofetilide and clofilium, which are widely prescribed for the management of 
tachyarrhythmias. Dofetilide is particularly effective in the treatment of atrial fibrillation 
(AF) and flutter (Jaiswal and Goldbarg, 2014). Unlike many other compounds, dofetilide is 
highly specific in its inhibition of IKr, leaving other channels involved in AP regulation 
unaffected (INa, IKs, ICa-L). In this study we used dofetilide at a sub-maximal concentration 
(30 nM) to partially inhibit IKr in select sub-populations of isolated cardiomyocytes from 
the sub-epicardial layer of rabbit hearts.  
6.1.3 Region-specific L-type Ca2+ channel inhibition 
The L-type Ca2+ channel is a voltage-dependent Ca2+ channel responsible for E-C coupling 
of skeletal, smooth and cardiac muscle. In cardiac myocytes, it acts by allowing extracellular 
Ca2+ to enter the cytoplasm upon depolarisation, thus modulating both contraction through 
available Ca2+ inside the cell, as well as membrane potential. ICa-L is responsible for the 
plateau (phase 2) of the action potential, opposing repolarising outward K+ channels, and 
slowly de-activating as the AP repolarises. Inhibition of ICa-L causes AP shortening, by 
offering no resistance to IKr and IKs, which quickly restore the cell membrane potential to 
its resting state. Nifedipine is a L-type channel blocker commonly used to treat high blood 
pressure (Olivari et al., 1979). Nifedipine reduces Ca2+ concentration inside the cytoplasm, 
thereby inhibiting muscle contraction. 
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6.1.4 Aims and hypotheses 
This chapter focuses on quantifying mean AP duration and repolarisation profiles of isolated 
rabbit myocytes originating from discrete cardiac regions both in healthy animals and in the 
rabbit MI model. 
To compare APD heterogeneity between heart regions, large samples of cells are required 
from each region to draw meaningful conclusions from population analyses. In this section, 
the mean behaviour and variability of action potential populations will be compared at 
several levels. Namely, the whole left-ventricle, endocardium and epicardium along the 
entire ventricle (transmural), and finally the epicardial basal and apical regions. These 
subdivisions of the heart muscle were chosen to maximise cell yield, irrespective of the 
isolation quality (i.e. cell survival %), by digesting large enough portions of tissue. This 
choice also allowed the clear delimitation of regions from one another, as the mid-
myocardium was discarded, and well as the central part of the epicardial surface to avoid 
any overlap between compared regions. 
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6.2 Methods 
6.2.1 Transmural APD variation 
Cells were isolated as previously described (Chapter 2). The left ventricle was dissected into 
endocardium and epicardium layers (~2 mm thick), and the mid-myocardium was discarded. 
Stock and sham rabbits were used for regional comparisons, specified where relevant. 
6.2.2 Sub-epicardial base and apex comparison 
The epicardium was dissected and separated in three parts, namely the base, middle, and 
apex. Cells were loaded with FluoVolt and paced at 2Hz at 37ᵒC, as previously described. 
 
Figure 6.1 Drug incubation and cell recording protocol. Timeline of drug effect protocol for 
isolated cells.  
Dish temperature was brought from RT to 37ᵒC, and pacing at 2Hz was maintained for 5 
min (2ms pulse, 40 volt). Action potential trains of 2.5s were recorded from each cell, after 
which pacing was halted and the drug was introduced to the medium. Drug incubation was 
carried out by replacing 10% of the total dish volume (200 µl) with 10X drug solution. 
Pacing was restored for 5 min, and action potential trains were again recorded from the same 
cells (see Figure 6.1). Cell locations were saved as XY coordinates in order to record the cell 
post-drug, using a computer-controlled stage. 
6.2.3 Pharmacological blockade of L-type Ca2+ and hERG 
channels  
All drugs used were prepared in 100% DMSO. Final DMSO concentration was kept low, at 
0.05%. hERG blockade was achieved using the specific IKr-blocker dofetilide. A 
concentration of 30 nM (0.05% DMSO) was used throughout. This sub-maximal 
concentration was selected to cause a robust AP prolongation at a pacing rate of 2 Hz. A 
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concentration of 30nM prolonged the AP and minimise the number of cells with APs 
prolonged beyond the cycle length (500 ms).  
L-type Ca2+ channel blockade was achieved using Nifedipine. A concentration of 1 µM 
(0.05% DMSO) was selected to achieve 50% blockade of the channel. 
All results shown as net effect after subtraction of vehicle effect (0.05% DMSO) if 
significant. 
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6.3 Results 
6.3.1 AP parameters throughout left ventricle sub-regions 
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Figure 6.2 Histogram of transmural and apicobasal differences. Histogram of APD90 
recorded across the LV wall in sub-endocardial and sub-epicardial cells (N=6) (left). 
Histograms of epicardial apical and basal cell APD90 (N=12) (right). 
Cardiac subregion comparisons (see Figure 6.2 and Figure 6.3) show extensive overlap of 
action potential durations between populations of cells, endocardium vs epicardium and 
epicardial base vs epicardial apex, with equivalent heterogeneity between groups, 
irrespective of region size (i.e. base and apex of epicardium vs entire epicardium). 
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Figure 6.3 Heterogeneity in the left ventricle Gaussian fit generated using the mean APD90 
and mean standard deviation obtained from populations of animals. 
Figure 6.3 shows the electrophysiological heterogeneity present within the myocardium is 
extensive, despite selecting reasonably small sub-regions (epicardial base and apex).  
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Figure 6.4 Intra-animal variation vs. inter-animal variation Intra-animal variation (open 
circles) shows the mean variation found within individual cell populations, and inter-animal 
variation (red circles) show the coefficient of variation of animal means, using the same 
datasets. 
Obtaining large numbers of cells from individual animals allows the accurate assessment of 
intra-heart variation (Mean variation present within each heart). This is not possible using 
lower-throughput techniques. Conventionally, the mean of each animal APD90 is sampled, 
and the variation between means is used to describe population variation. As shown in Figure 
6.4, this both underestimates the heterogeneity present, and additionally causes loss of inter-
animal variation: there is no error on the mean. 
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6.3.2 Region-specific ICa-L block using Nifedipine 
 
Figure 6.5 Effect of ICa-L block on APD90 in sub- endocardium and sub-epicardium. Box plots 
of APD90 in populations of cells sampled from apex and base of the sub-epicardial surface 
before (baseline) and after treatment with 1 µM nifedipine. Both regions display significant 
decrease in mean APD90 after drug treatment (Paired t-test, P<0.001). Vehicle (DMSO) 
shows no significant change. 
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Figure 6.6 Net APD effect of 1 µM nifedipine on APD90. Scatter plot of net drug effect on 
APD90 against baseline APD90. (a) Basal cells. (c) Apical Cells. A linear regression was 
fitted to each cell population to determine the relationship between starting APD and 
observed drug effect (red). 5/6 basal cell populations and 6/6 apical cell populations 
displayed a negative linear correlation with a mean gradient of -0.26x±11 and -0.31x±7, 
respectively. (b) Overlapping histograms of APD90 change after drug in basal cells and (d) 
apical cells. 
Not all cells experienced APD shortening, although the vast majority did. The APD-
shortening effect appears to be non-uniform in both regions. The APD-shortening effect was 
positively correlated with baseline AP duration in 11 out of 12 animals between both basal 
and apical cells, indicating drug effect was influenced by the initial baseline state of each 
cell, rather than imposing a constant change across all cells. 
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6.3.3 Region-specific hERG block using Dofetilide 
 
Figure 6.7 Effect of IKr block on APD90 in sub- endocardium and sub-epicardium Box plots 
of APD90 in populations of cells sampled from apex and base of the sub-epicardial surface 
before (baseline) and after treatment with 30 nM dofetilide.  
Both regions display significant increase in mean APD90 after drug treatment (Paired t-test, 
P<0.001). Vehicle (DMSO) shows no change. Note the APD of cells whose AP prolonged 
beyond the pacing cycle length (500 ms) could not be quantified. The net APD prolonging 
effect seen here is therefore likely an under-estimation (discussed in p124). 
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Figure 6.8 Net effect of 30 nm treatment on APD90.  Scatter plot of net drug effect on APD90 
against baseline APD90 by individual cells (paired) in response to 30 nM dofetilide. The 
scatter plots show the theoretical maximum measurable ∆ while pacing at 2 Hz (red area). 
(b) Overlapping histogram of APD90 change (paired) after drug in basal cells and (d) apical 
cells. 
The APD-prolonging effect of dofetilide appears to be uniform in both regions. The vast 
majority of cells (> 85%) experienced AP prolongation following treatment. There was no 
strong evidence of correlation between baseline and recorded effect on APD, as 6/12 cell 
populations showed no correlation (p>0.05). Of the remaining 6 cell populations with linear 
regressions significantly deviating from zero, 4 were negative and 2 positive. As discussed 
later, a proportion of cells (hyper-responders, see Figure 6.9) experienced APD prolongation 
beyond 500 ms, and their APD could therefore not be measured.  
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6.3.3.1 Hyper-responders 
Following 30 nM dofetilide treatment, mean APD90 increased by 30±2ms in basal cells, and 
by 21±2 ms in apical cells (Paired t-test; P<0.001, respectively). The ∆APD90 (net change 
following dofetilide) was plotted against baseline APD90 to determine whether this effect 
was uniform across cells. The APD prolongation appeared uniform, and consequently was 
not dependent on baseline APD. Sub-groups of cells (up to 50%) from each heart region 
experienced AP prolongation to values beyond the pacing cycle length (>500ms). The mean 
baseline APD90 from these cells was not significantly different from normal-responders 
(Base: 277±9 ms vs. 282±4 ms; Apex: 299±5 ms vs. 290±4 ms respectively; Unpaired t-test, 
P > 0.05). 
While the APD90 for these hyper-responders could not be determined (APD > CL), we 
calculated the minimum ∆APD90 they had to have experienced to reach an APD ≥ 500 ms. 
The ∆APD90 for each cell was calculated as: 
𝐶𝐿 (𝑚𝑠) − 𝐴𝑃𝐷90(Baseline) (𝑚𝑠) 
Using the minimum ∆ from the hyper-responders, the mean APD increase in basal and apical 
cells are calculated to be 55±4 ms and 56±5 ms, compared to 36±3 ms a and 21±4 ms, 
respectively. This measure of mean prolongation can only serve as a conservative estimate, 
and we can confidently assert this is the minimum effect observed, and likely to be higher, 
however the absolute value cannot be inferred from these data alone. 
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Figure 6.9 Example of a typical responder and a hyper-responding cell AP train. (a) Normal 
and (b) hyper-responding cells prior to drug treatment. (c) Cell AP train following 
incubation with 30 nM dofetilide. The pacing stimulus (red arrows) shows when the cell 
was electrically stimulated. (d) The hyper-responder AP exceeded the protocol pacing 
interval (500ms) and consequently depolarised every second beat (1:2). No EADs were 
seen in either group. 
 
Figure 6.10 Comparison of normo- versus hyper-responding cell baseline AP duration. 
Normal responders (grey) and hyper-responders (black) are not significantly different 
(P=0.31 and P=0.051, respectively.) and appear to follow the same distribution pattern. 
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The percentage incidence of hyper-responders ranged from none to 50% from animal to 
animal at the same drug concentration. 
The incidence of hyper-responders varied considerably between animals, and between 
regions (see Figure 6.10). The average incidence of hyper-responders in basal cells was 
9.5±4%, and 19.2±4% in apical cells. 
Conclusions 
6.4 Transmural variation 
Repolarisation heterogeneity was investigated both along the transmural and longitudinal 
axes of the rabbit myocardium. Measures of variation used were standard deviation, 
interquartile range and coefficient of variation. These were selected to complement their 
respective sensitivity to outliers, giving a better picture of heterogeneity than any individual 
measure could. Variation was assessed at three levels: (1) within a single region of 
myocardium, (2) between regions of the same heart and (3) between hearts. The intrinsic 
variation present in isolated cells is vastly greater than in electrically coupled tissue. 
Interestingly, the spread of APD90 observed in any region of the myocardium, irrespective 
of its relative size/volume (e.g. basal sub-epicardium), appears to be comparable in 
repolarisation heterogeneity to the whole ventricle in healthy tissue. This suggests different 
electrophysiological behaviours across the LV wall are exhibited as a mean shift, with 
comparable spread of cell-specific behaviour, irrespective of the cell’s location in the wall. 
6.5 APD modulation in epicardial sub-regions 
6.5.1 Nifedipine 
Using nifedipine to shorten the action potential was done to assess the homogeneity of 
response on a cell to cell basis. As hypothesized, the net drug effect was not homogeneous 
among cell populations. Rather than produce an average shortening in APD applicable to all 
cells, ICa-L block produced a graded effect, where cells with “long” APs experienced more 
pronounced AP shortening than cells with intrinsically “shorter” APs. This effect was 
significant in 5/6 animals. 
Moreover, blocking ICa-L should always shorten APD. Interestingly, a very small number of 
cells from each sample experienced modest AP prolongation following drug treatment. 
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Although cell damage could play a role in this, it is likely to have been caused by APD 
variation of the second measurement. This requires investigation of repeat-measurement 
variability over time in a large group of control cells (Time control).  
While this effect may be an artefact of intrinsic variation as a result of the technique, current 
models taking an agnostic approach to experimental dataset calibration are not incorporating 
this variable (i.e. ICa-L block on a modelled cell will always cause AP shortening, by 
definition). Adding measurement noise (time control) when calibrating models using 
fluorescence-based experiments may improve current models. 
6.5.2 Dofetilide 
6.5.3 Hyper-responders 
Mean APD following hERG blockade was significantly increased, but this was also not 
homogeneous across the cell populations tested. Following 30 nM dofetilide treatment, the 
APD response was either moderate and constant (~10% increase from baseline) or extreme 
(≥80% increase). The striking feature of these latter hyper-responding cells was that their 
baseline APD was undistinguishable from other cells prior to drug treatment. Lastly, the 
incidence of these hyper-responders varied between hearts and between apex and base, 
accounting for up to 50% of the cell populations sampled from individual animals. These 
differences in the nature of hyper-responders need to be investigated more systematically. 
Very few cells failed to respond to the drug treatment, with a select few experiencing APD 
shortening. Negative responders could be explained by an excitatory threshold shift in these 
cells, causing incomplete APs in response to a constant stimulus (very short duration, smaller 
amplitude positive voltage deflections). A method for testing for this would be to assess the 
signal-to-noise of each cell prior to and following drug incubation. Any substantial drop in 
SNR would indicate the amplitude of the pseudo-action potential results from sub-threshold 
depolarisation and should be discarded. 
Experimentally calibrated model populations have been used recently (Britton et al., 2013) 
to investigate the mechanisms of variation to drug response in Purkinje fibers. Using wide 
ion channel conductance limits (up to ±100%), they successfully predicted ∆APD response 
to dofetilide in Purkinje fibers. Using these experimental constraints, no evidence for bi-
modal response to drug was reported. The experimental sets used to calibrate these models 
consisted of microelectrode recordings of 6 preparations of Purkinje fibers, although the 
number of animals used is not specified. It is conceivable that cellular coupling in their 
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preparations could mask measures of variability, and that sample size contributed negatively 
to estimates of variation derived from these experiments. Using large sample sizes from 
several animals could therefore contribute to improving estimates of variation. 
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7 Chapter 7 General Discussion 
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7.1 Summary 
The work carried out as part of this thesis was organised into two discrete results categories. 
The first was the successful leap from low to medium-throughput sampling of simultaneous 
voltage and calcium information from large sample populations of isolated cells (CMs) from 
a single animal. The second was the implementation of this new technique to investigate the 
scale and implications of biological variation on a cell to cell basis following MI, and 
additionally specific channel blockade using cell populations from small cardiac subregions. 
7.2 Electrophysiological findings 
The application of a medium-throughput technique allowed the first quantification of 
heterogeneity on cell populations within the ventricle wall, in healthy animals, and following 
myocardial infarction. Interestingly, the variation in repolarisation in any given region of the 
ventricle was found to be considerable, and far outweighed any differences found between 
discrete regions. This large variation did not limit the ability of the technique to identify 
small electrophysiological differences due to large sample sizes. This finding strongly 
suggests that variation in conductance of key ion channels may currently be underestimated 
by electrophysiological models (Britton et al., 2013), and should be incorporated in current 
models to better estimate drug response across populations. As mentioned previously, 
experimentally calibrated model populations have potentially suffered from inconsistent 
reports of cell-cell and heart-heart variation, where cell groups from multiple hearts were 
pooled, inadvertently combining inter- and intra-heart variation. Incorporating 
medium/high-throughput experiments consequently has the potential to improve the 
predictive power of current models, and additionally by providing a measure of inter-, as 
well as intra-subject variability. 
Following infarction-induced remodelling over several weeks, mean action potential 
prolongation was observed at slow frequencies (1 Hz and 2 Hz), but was not present at 3 Hz. 
Heterogeneity between cells was, however, not found to increase significantly in any of the 
voltage parameters measured. Variation in repolarisation duration between MI animals did 
not increase significantly between MI and controls, which could reflect a variable response 
to injury from animal to animal. The relatively small number of animals used could not 
substantiate this finding (N = 7-9), however it is plausible a small change in cell-cell 
variation exists, which the study was insufficiently powered to detect. Lastly, the pacing rate 
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of 2 Hz used throughout may have masked heterogeneity, which could be revealed at slower 
rates. 
Transmural analysis of individual heart electrophysiology following infarction found a loss 
of the transmural APD gradient, whereby infarcted left ventricles produced sub-endocardial 
and sub-epicardial cells with prolonged repolarisation durations, blurring the boundary 
between regions. While action potential duration was significantly increased in both sub 
endocardial and sub-epicardial cells, the increase was greater in the sub-epicardium. 
Triangulation, normalised to action potential duration, was not different between regions or 
following MI, suggesting reports of increased triangulation in literature may in part be 
positively skewed by comparing APs of different durations. Region-specific remodelling has 
been reported previously (McIntosh, Cobbe and Smith, 2000; Lou, Li and Efimov, 2011). 
Heterogeneity was not found to increase between regions, save for a modest increase in 
triangulation CoV of the sub-endocardium in MI animals. The AP upstroke was the most 
variable parameter assessed, attributable to both its sensitivity to Na+ channel variation, as 
well as measurement error (i.e. millisecond event resolution is at the lower limit of current 
technique precision). 
While no significant difference was found in measures of APD heterogeneity between 
healthy regions of infarcted and sham animals, a trend increase in variation is visible in the 
cell populations (all animals pooled). As mentioned, the infarct and peri-infarct tissue were 
removed in both groups. This served as a robust comparison between remodelled and non-
remodelled tissue, but may also give an incomplete representation of variability present in 
MI. This finding does however support the idea that the cause of increased arrhythmic risk 
following MI stems from a localised mean change in APD (i.e. loss of transmural gradient) 
rather than increased heterogeneity in the non-infarcted regions of remodelled myocardium. 
Inclusion of peri-infarct cells may tell a different story. 
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7.3 Cell population response to channel block 
The action potential duration was modulated through ICa-L and IKr blockade in left-ventricular 
subregions. The behaviour of cell populations from both regions studied was not 
homogeneous in response to either prolongation or shortening of the APD. Blockade of L-
type Ca2+ channels produced a baseline-dependent AP shortening, whereby 80% of animals 
tested displayed a linear correlation between drug effect and baseline state in paired cells. 
Blocking IKr produced moderate APD prolongation in the majority of cells, and revealed a 
sub-population of cells exhibiting extreme APD prolongation. The type of response was not 
predictable from baseline APD. 
The probable reason for the baseline-dependence of L-type Ca2+ blockade, where cells with 
short APs show the smallest degree of APD shortening, is that these cells have smaller 
calcium transients. The consequences of having smaller calcium transients are a reduced 
calcium transient amplitude, which directly translates to reduced fractional shortening. In 
turn, cells with larger transients can respond more variably to ICa-L block, denoted by a wider 
range of ∆APD90 toward the longer range of baselines than at the short range (Figure 6.6). 
Future work should aim to compare calcium transient duration and amplitude together with 
APD and fractional shortening in response to pharmacological intervention. 
Contrasting the above, hERG blockade using dofetilide did not produce baseline dependent 
APD prolongation. The highly variable spread of ∆APD90 in response to treatment suggests 
a large physiological range of hERG expression in cardiomyocytes, irrespective of their 
APD. A curious feature was the sub-group of “hyper-responding” cells with a very different 
response, despite having the same baseline as normal responders. The reason behind this 
sub-population is not known. A possible mechanism is that cells with large hERG expression 
also have small ICa-L expression, which would result in comparable APD at rest, but 
disproportionate APD prolongation in response to IKr block. Under these conditions, similar 
fractional inhibition of hERG could produce disparate effects on APD. The Sobie group 
found increasing IKs in several computational models increased heterogeneity in CM 
populations. They also tested IKs contribution to EAD propensity in models with a wide 
range of ICa-L expression, and found high levels of IKs was protective against EAD 
generation. 
To test this hypothesis, comparing calcium transients and fractional shortening with APD in 
these two cell groups is a necessity. Another approach to testing this is using computational 
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modelling to simulate the response of a population of cells with a wide range of ion channel 
expression to an identical fractional inhibition of IKr. This will test whether this behaviour 
is simply a product of the inherent variability present in isolated cell ion channel expression. 
In the event that hyper-responding cells are in fact physiological, then what contribution this 
sub-population makes to the overall response to hERG block needs to be investigated. 
Finally, in pathology, after remodelling of the myocardium, the range of electrophysiological 
phenotypes may have been altered, potentially also affecting hyper-responding cells.  
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7.4 Inter-heart and intra-heart variation in APD 
The technique used in this permitted large groups of cells to be sampled from individual 
hearts, quantifying variation (SD, CoV) accurately. In this way it became possible to study 
the magnitude of variation present between normal and pathological conditions caused by 
MI. Furthermore, it also allowed inter-heart and intra-heart variation to be assessed 
separately. 
Isolated cell publications commonly mix these two variables and report mixed SEM and SD 
values. Table 5 summarises and contrasts some of the literature on rabbit APD in single cell 
and intact myocardium. The latter includes detailed optical measurements from a current 
unpublished study (C. Alexander, personal communication, see Table 5). 
Single cell data from endocardial and epicardial sites suggests an intra-heart APD CoV of 
15-20%. Based on the mean APD from each animal, the inter-heart APD was ~10%. These 
numbers span the estimates of CoV based on published data (Table 5). The CoV from the 
combined data (all cells from all animals as is conventionally done) is approximately 15%. 
This compares with data from the intact myocardium which suggests that intra-heart 
variation is considerably less than that seen in single cells. The variation from region to 
region in each heart is approximately 3-4%, (i.e. ~20% of that seen in single cells). This 
reduced variation is due to the electrical coupling between cells, which minimises 
differences. The inter-heart differences are approximately the same value. The smaller 
spread may also be due to lower APD values in intact hearts at equivalent rates (i.e. ~170 
ms vs ~270 ms at 2Hz). 
Combining the CoV from intra-heart and inter-heart variation, to predict the global CoV 
value is complex. Estimates of the predicted value were based on modelling theoretical 
values using random variation of APD values. The relationship between the two is shown in 
the appendix (Table 6). These indicate that for an intra-heart CoV of ~10%, and an inter-
heart of ~15%, the global CoV will be ~18.5%, which closely matches the value of 18.4% 
measured in this study. Interestingly, the relationship between inter- and intra-heart variation 
shows that the very small CoV observed within intact hearts would mean that global (all 
cells pooled) CoV is dominated by the inter-heart variation rather than the intra-heart CoV. 
In contrast to studies in single cells. This strongly suggests a hierarchical statistical approach 
is essential for analysis of these data, as advised in a recent publication (Sikkel et al., 2017).
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 Source Heart region Pacing 
frequency (Hz) 
Mean 
APD90(ms) 
CoV 
(INTRA) 
CoV 
(INTER) 
Compound 
CoV 
Predicted 
variation 
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and Smith, 2000) 
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sub-epicardium 1 170  15.4 % --   
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(Saegusa, Garg and 
Spitzer, 2013) 
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Q. Lachaud 
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7.5 Technique achievements, limitations and 
improvements 
The methodology developed in this thesis is now capable of recording transient changes in 
membrane voltage, calcium concentration, and contraction kinetics in large populations of 
isolated cells from single animals. The novel aspect of this method over available 
commercial technology is a combination of elements: (1) a highly sensitive, high sampling 
rate fluorescence-recording apparatus, (2) a custom-built microscope stage 
incubator/stimulator combined with a bright fluorophore and (3) a proprietary, flexible 
software platform controlling the hardware, and providing user-controlled, tailored trace 
analysis. The combination of these main components constitutes a significant improvement 
on the methodologies used prior in the field of fluorescence-based electrophysiology, by 
improving signal sensitivity, temporal resolution, increasing experimental throughput, and 
coincidentally reducing animal usage. 
The current limitations of this method involve spectral overlap of the various dyes used, and 
concomitant limitations with regards of wavelength bands which can be sampled from 
simultaneously without requiring changes in hardware, such as wavelength filters or 
excitation sources. The top-end sampling limits of the system, while comparatively very 
high, have been identified and optimised to increase recording consistency and repeatability, 
specifically pertaining to very fast events like the action potential upstroke. In other words, 
the upstroke of the action potential is still challenging to accurately measure. Using 
consistent filtering techniques helped make comparative measurements, but accurately 
quantifying the absolute duration of the upstroke still requires faster sampling rates. 
The next logical step for this technique is automating the last aspect of human involvement. 
Visually inspecting cell health and manually enclosing the FOV onto individual cells is the 
most time-consuming and subjective step of the protocol. Removing this step has the 
potential to increase the throughput of the technique a further 3 to 10-fold. A possible 
workaround for this is a systematic recording of all cells identifiable in the dish using lower 
magnification (x5-x10) and image analysis to identify isolated cell locations and map them. 
Once the isolated cell positions are recorded, CellOPTIQ could then systematically record 
all available metrics (action potentials, calcium transients, contraction kinetics, cell size) in 
all cells and a post hoc quality assessment can be carried out by a human. 
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Conversely, at the expense of sampling rate, a CCD camera could be used to record 
fluorescence continuously from a large FOV, and fluorescence analysis can be carried out 
post hoc. 
7.5.1 Future work 
The next steps in the development of this powerful technique can be divided in two parts: (i) 
further improving the sampling throughput from single hearts, by automating cell targeting 
and (ii) integrating isolated cell experiments with whole heart studies. Improving throughput 
is currently limited by human input. Using live image analysis could allow the identification 
of viable cells automatically in the dish, and the systematic recording of fluorescent signals. 
Pairing medium throughput cell studies with whole heart or wedge experiments would 
enable pairing whole organ information (ECG, epicardial and transmural APD dispersion) 
with isolated cell information (region-specific Ca2+ and voltage information). A further step 
would be to pair functional (contraction, voltage and calcium) measurements with protein 
assessment of individual cells which could yield further insight into the relationship between 
ion channel expression ratios and APD heterogeneity between cells and individuals.  
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8 Appendix 
8.1 Trace deconvolution Python 3 code 
 
import numpy as np 
from matplotlib import pyplot as plt 
import glob 
import os 
 
home = 'C:/Users/Quentin Lachaud/Desktop/Deconvolution_traces/' 
 
#Define correlation function variables: 
factor2 = 0.5 
factor1 = 0.09 
constant1 = 278 
constant2 = 354 
 
#define corrective function 
def correct(AP,Ca,factor,constant): 
     
    corr = Ca-(AP * factor + constant) 
    return corr 
 
#look in each channel folder for csv files 
ca1 = glob.glob(home + 'Ch1/*.csv') 
ca2 = glob.glob(home + 'ch2/*.csv') 
V1 = glob.glob(home+ 'ch4/*.csv') 
 
#assign channel to array from files 
for i in range(len(ca1)): 
    ch1 = np.loadtxt(ca1[i], delimiter = ',') 
    ch2 = np.loadtxt(ca2[i], delimiter = ',') 
    ch4 = np.loadtxt(V1[i], delimiter = ',') 
     
#correct each channel and remove non-overlapping timeseries to calculate ratios 
    ratio = ch1[:,1]/ch2[:,1] 
    corr1 = correct(ch4[2:,1],ch1[1:-1,1],factor1, constant1) 
    corr2 = correct(ch4[2:,1],ch2[:-2,1],factor2, constant2) 
    corr_ratio = corr1/corr2 
     
#Create corrected ratio folder and analysis folder 
    ratio_folder_path = home + 'ratio/' 
    corr_folder_path = home +'corr_ratio/' 
    corr_analysis = home + 'ratio_analysis/' 
    if not os.path.exists(ratio_folder_path): 
        os.makedirs(ratio_folder_path) 
    if not os.path.exists(corr_folder_path): 
        os.makedirs(corr_folder_path) 
    if not os.path.exists(corr_analysis): 
        os.makedirs(corr_analysis) 
         
#Save corrected ratios to new folder 
    np.savetxt(ratio_folder_path + 'ratio'+str(i)+'.csv', ratio) 
    np.savetxt(corr_folder_path +'ratio'+str(i)+'.csv', corr_ratio) 
 
#look inside corrected ratios folder and load their data into "trace" to plot 
sequentially 
corrected_ratios = glob.glob(corr_folder_path + '*.csv') 
ratios = glob.glob(ratio_folder_path + '*.csv') 
 
 
for i in range(len(corrected_ratios)): 
    corr_trace = np.loadtxt(corrected_ratios[2]) 
    old_trace = np.loadtxt(ratios[2]) 
 
#make comparative figures side by side 
    plt.subplot(1,2,1) 
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    plt.title('Original Ratio') 
    plt.plot(old_trace, 'b', linewidth = 1) 
 
    plt.subplot(1,2,2) 
    plt.title('Corrected Ratio') 
    plt.plot(corr_trace, 'red', linewidth = 1) 
 
#plt.show() 
 
 
8.2 Hierarchical analysis using R 
The following code and use instructions were taken from Sikkel et al., 2017. The script 
was adjusted to an example file analysed in this thesis. 
library(lmerTest) #If told 'there is no package called 'lmerTest', run 'install
.packages("lmerTest")' 
## Loading required package: lme4 
## Loading required package: Matrix 
##  
## Attaching package: 'lmerTest' 
## The following object is masked from 'package:lme4': 
##  
##     lmer 
## The following object is masked from 'package:stats': 
##  
##     step 
require(readxl) #If told 'there is no package called 'readxl', run 'install.pac
kages("readxl")' 
## Loading required package: readxl 
This prevents scientific notation for p values unless they are very small. 
options(scipen=999) 
Now we load the excel spreadsheet into the variable ‘input data’. 
file_location = "C:\\Users\\Quentin Lachaud\\Desktop\\PhD\\R scripts for hierar
chical stats\\Hierarchical MI_APD90.xlsx" 
input_data <- read_excel(file_location) 
#This loads the excel spreadsheet into the variable 'input data' 
Here we rename the column of our condition (e.g. heart failure or not) to ‘Condition’, and the grouping 
variable (e.g. rat) to ‘Group’. 
We then ensure that the condition and group columns are treated as categorical variables (factors) rather than 
a continuous numerical value. 
Finally, we create an empty results table. 
names(input_data)[1] <- "Rabbit" 
names(input_data)[2] <- "Region" 
 
input_data[2] <- as.factor(unlist(input_data[2])) #Ensure the Condition group i
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s treated as a categorical variable (distrinct groups) rather than continuous n
umerical values 
input_data$Rabbit <- factor(input_data$Rabbit) #Ensure the Rat group (Group) is 
treated as a categorical variable (distrinct groups) rather than continuous num
erical values 
 
df_output <- data.frame() #Create an empty main results table 
df_output_lsmeans <- data.frame() #Create an empty results table for least squa
red means 
df_output_pairwise <- data.frame() #Create an empty results table for the pairw
ay comparisons 
This is the main ‘loop’ of the code, which runs once for each dependent variable in our spreadsheet. 
for(APD90 in names(input_data[,3:ncol(input_data)])) { #This for loop ensures t
he indented code between the curly braces runs once for each column (dependent 
variable) from the 3rd column onwards 
  # STEP 1. Fit a NON-Hierarchical model (equivalent to a t-test) 
  #Fit a model, calculate the standard error, p value, and -2 log Likelihood 
  NON_hierarchical_model <- glm(get(APD90) ~ Region, data=input_data) #This fit
s a generlised linear model for each dependent variable and the output column (
HF_or_control; the presence or not of heart failure) and stores it in the varia
ble named NON_hierarchical_model 
  se_NON_hierarchical_model <- summary(NON_hierarchical_model)$coefficients[, 2
][1] #This extracts the standard errors from the model and stores it in a new v
ariable named se_NON_hierarchical_model 
  p_NON_hierarchical_model <- summary(NON_hierarchical_model)$coefficients[, 4]
[1] #This extracts the standard errors from the model and stores it in a new va
riable named p_NON_hierarchical_model 
  goodness_of_fit_NON_hierarchical_model <- logLik(NON_hierarchical_model)*-2 #
We calculate a goodness of fit using the -2 logLikelihood of the model and save 
it in a new variable named goodness_of_fit_NON_hierarchical_model 
   
  # STEP 2. Fit a Hierachical model 
  # Step 2a. Fit a model, calculate the standard error, p value and -2 log Like
lihood 
  hierarchical_model <- lmer(get(APD90) ~ Region + (1 + Region|Rabbit), REML=FA
LSE ,data=input_data) #We now fit a linear mixed effects (hierarchical) model a
nd store that in the variable named hierarchical_model. We fit each dependent v
ariable against the Output column, with 'Rat' as a group effect 
  se_hierarchical_model <- summary(hierarchical_model)$coefficients[, 2][1] #As 
previously, extract the standard errors and store them in a variable 
  p_hierarchical_model <- summary(hierarchical_model)$coefficients[ ,5][1] #As 
previously, extract the p values and store them in a variable 
  goodness_of_fit_hierarchical_model <- logLik(hierarchical_model)*-2 #As previ
ously, calculate a goodness of fit and store it in a variable 
   
  # STEP 2b. Calculate amount of clustering, defined as the intraclass correlat
ion, a value between 0 and 1  
  table_of_variances <- as.data.frame(VarCorr(hierarchical_model)) #Create a da
taframe (table) of the covariance parameters called 'table_of_variances' 
  variance_of_means <- table_of_variances$vcov[2] #Extract the variance of the 
mean from the 'table_of_variances' and store it in a variable names 'variance_o
f_means' 
  variance_of_individual_datapoints <- (table_of_variances$vcov[2] + table_of_v
ariances$vcov[1]) #The total variance is also extracted, as defined as the vari
ance of the rat model plus the residual variance 
  icc <- variance_of_means / variance_of_individual_datapoints #The intra-class 
correlation (ICC) is calculated and defined by the variance of the model divide
d by the total variance 
   
  # STEP 2c. Calculate goodness of fit and see if higher for hierarchical model 
  improvement_in_goodness_of_fit <- goodness_of_fit_NON_hierarchical_model - go
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odness_of_fit_hierarchical_model #We calculate the difference between theprevio
usly-calculated goodness of fit for both the non-hierarchical and hierrachical 
models; this difference is stored in the variable improvement_in_goodness_of_fi
t 
  betterfit <- 1-pchisq(improvement_in_goodness_of_fit[2],df=1) #The p value fo
r whether the hierarchical model is a significant improvement is calculated usi
ng the Chi-squared distribution with 1 degree of freedom 
  p_betterfit <- ifelse(betterfit<0.0001,"<0.0001",round(betterfit,digits=4)) #
If the p value calculated above is very small, we just replace it with "<0.0001
" 
  superiorp <- ifelse(improvement_in_goodness_of_fit>0 & betterfit < 0.05,paste
("Y (", p_betterfit ,")",sep=""),paste("N (", betterfit, ")",sep="")) #If there 
is an improvement in the goodness of fit and the p value is less than <0.05, we 
set the variable 'superiorp' to "Y", otherwise "N" 
   
  # STEP 3 Calculate least squares means for each group of the outcome variable
s, and the pairwise comparisons 
  lsmean <- lsmeansLT(hierarchical_model) #We calculate the least squares means
, standard errors and confidence intervals for the different outcomes (e.g. pre
sence and absense of heart failure) 
  row.names(lsmean) <- paste(APD90,row.names(lsmean),sep=" - ") #Add the curren
t variable in question to the row name 
  difflsmean <- difflsmeans(hierarchical_model) #We test for significance betwe
en the different outcome levels 
  row.names(difflsmean) <- paste(APD90,row.names(difflsmean),sep=" - ") #Add th
e current variable in question to the row name 
   
  df_output <- rbind( #We add the results to our main results table in this fun
ction 
    df_output, 
    data.frame( 
      CommonSE=round(se_NON_hierarchical_model,digits=3), #Add the standard err
or of the non-hierarchical model 
      Commonp=ifelse(p_NON_hierarchical_model<0.0001,"< 0.0001",toString(round(
p_NON_hierarchical_model,digits=4))), #Add the p value of the non-hierarchical 
model; if it's very small, replace it with "< 0.0001"" 
      ICC=paste(round(icc*100,digits=1),"%",sep=""), #Add the intraclass correl
ation of the hierarchical model 
      MixedSE=round(se_hierarchical_model,digits=3), #Add the standard error of 
the hierarchical model 
      Mixedp=ifelse(p_hierarchical_model<0.0001,"< 0.0001",toString(round(p_hie
rarchical_model,digits=4))), #Add the p value of the hierarchical model; if it'
s very small, replace it with "< 0.0001"" 
      Superioryn=superiorp #Add a column indicating if the hierarchical model i
s a statistically significantly better fit (Y or N) and the actual p value 
    ) 
  ) 
 
  df_output_lsmeans <- rbind( #We add the results to our ls squares results tab
le in this function 
    df_output_lsmeans, 
    lsmean 
  ) 
   
  df_output_pairwise <- rbind( #We add the results to our pairwise comparisons 
results table in this function 
    df_output_pairwise, 
    difflsmean 
  ) 
   
  row.names(df_output)[nrow(df_output)] <- APD90 #Set the name of the row to th
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e dependent variable in questions 
} 
Finally, we specify the column headings here and print the table. 
names(df_output) = c("Common test (SE)","Common test (p)","Group-level clusteri
ng (ICC)","Group-level (SE)","Group-level (p)","Superior fit (p)") #Set the col
umn headings 
print(df_output) #Output the summary table 
Here we output a table containing the least squares means and confidence intervals for each outcome, 
grouped by each dependent variable. 
cols.dont.want <- c("DF", "t-value", "p-value") 
df_output_lsmeans <- df_output_lsmeans[, ! names(df_output_lsmeans) %in% cols.d
ont.want, drop = F] 
print(df_output_lsmeans) #Output the results table for LS means 
Here we output the pairwise comparisons. P values are multiplied by the number of comparisons to 
maintain a type 1 error rate of 5% (Bonferroni correction) The results are rabbited for each output variable 
(left column), with each combination of outcomes undergoing significance testing. 
cols.dont.want <- c("DF", "t-value", "Lower CI","Upper CI") 
df_output_pairwise <- df_output_pairwise[, ! names(df_output_pairwise) %in% col
s.dont.want, drop = F] #Remove the unwanted headings from the table 
df_output_pairwise$`p-value` <- df_output_pairwise$`Pr(>|t|)` * ( nrow(df_outpu
t_pairwise) / length(names(input_data[,3:ncol(input_data)])) ) #Multiply the p 
values by the number of comparisons per dependent variable 
names(df_output_pairwise)[names(df_output_pairwise)=="p-value"] <- "Bonferroni 
p-value" #Change the column heading 
df_output_pairwise[df_output_pairwise$`Bonferroni p-value` > 1,"Bonferroni p-va
lue"] <- 1 #Change any p value above 1 to 1 
print(df_output_pairwise) #Output the results table for the pairwise comparison
s 
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